Ophthalmology · Full case

Dry Eye Disease

NICE CKSDEWS IILubricant Drops
DE
Dry Eye Disorder · Clinical Reasoning Framework v2
GP & SCA · NICE CKS · DEWS II · Lubricant Drops · Preservative-Free · MGD · Lid Hygiene · Sjögren’s Screen · Medication Review · Evaporative DED
Preservative-free if >4×/dayBenzalkonium chloride (BAK) is the most common preservative in eye drops. Used >4 times/day: BAK accumulates on the ocular surface; is directly toxic to corneal epithelial cells; disrupts the tear film; and worsens dry eye disease — the very condition being treated. Preservative-free drops (sodium hyaluronate; Hylo-Forte; Hylo-Comod; Clinitas; carmellose preservative-free) must be prescribed if the patient requires drops more than 4 times daily. Also essential for: contact lens wearers (BAK absorbed into lenses; concentrated release); known BAK sensitivity; post-surgical eyes. Preserved drops are appropriate for mild DED (<4×/day use). Cost implication: preservative-free drops cost more — but the harm from preserved drops at high frequency is a clinical reason to prescribe PF despite cost.
20-20-20 rule (screen use)Prolonged screen use reduces blink rate from 12–15 blinks/minute to approximately 3–8 blinks/minute. Each blink spreads and renews the tear film — reduced blinking accelerates tear evaporation and is the primary driver of screen-related dry eye disease. The 20-20-20 rule: every 20 minutes of screen use; look 20 feet (6 metres) away for 20 seconds — this promotes blinking and allows tear film recovery. Additional screen advice: position screen below eye level (reduces exposed ocular surface area); increase text size (reduces need to focus intensely with reduced blink); set up screen reminders; use a humidifier. For Mrs. Chen (8+ hours screens/day as accountant): this is the most immediately modifiable lifestyle trigger.
MGD: most common type (∼85%)Meibomian gland dysfunction (MGD) causes evaporative dry eye disease — the most common type (approximately 85% of dry eye disease). Meibomian glands (approximately 30–40 per lid) secrete lipids that form the outer tear film layer, which retards evaporation. MGD → reduced lipid secretion → accelerated evaporation → tear film instability → DED symptoms. Clinical signs of MGD: lid margin erythema and telangiectasia; thickened lid margins; capped or absent meibomian gland orifices; turbid or absent meibum on expression; blepharitis. Treatment: warm compresses (softens meibum) + lid massage (expresses meibum) + lid hygiene (removes debris). These are first-line for evaporative DED and must precede or accompany lubricant drops for full effect.
Paradoxical epiphora = reflex tearingOne of the most counterintuitive features of dry eye disease: patients often present with watery; streaming eyes (epiphora) rather than or alongside dry eye symptoms. Mechanism: insufficient basal tearing → corneal irritation → trigeminal nerve stimulation → reflex lacrimal gland secretion → excessive watery tears. These reflex tears are of low quality (lacking the mucin and lipid layers) and wash away rapidly, leaving the corneal surface exposed again. The patient’s “watery eyes” are not over-production — they are a symptom of the underlying dry eye causing corneal irritation. This must be explained: “The watering is your eye’s attempt to compensate for the dryness — but reflex tears are not the same quality as natural tears and do not fix the underlying problem.”
Sjögren’s screen: anti-Ro; anti-La; ANASjögren’s syndrome causes dry eyes + dry mouth (sicca syndrome) — the most important systemic cause of aqueous-deficient dry eye. Primary Sjögren’s: sicca features alone. Secondary Sjögren’s: with rheumatoid arthritis; systemic lupus erythematosus; systemic sclerosis; primary biliary cholangitis. Screen: anti-Ro (SS-A) — most sensitive; anti-La (SS-B) — more specific; ANA; rheumatoid factor. Schirmer’s test <5mm/5 minutes = severe aqueous deficiency (usually done by ophthalmology/optometrist). If Sjögren’s suspected: also check FBC (lymphopenia); ESR; CRP; complement (C3/C4); immunoglobulins; salivary gland USS — and refer to rheumatology. Sjögren’s has significantly increased lymphoma risk (40–60× general population) requiring appropriate long-term monitoring.
OSDI: 0–100 severity scoreThe Ocular Surface Disease Index (OSDI) is the validated patient-reported outcome measure for dry eye disease severity, recommended by NICE CKS for use in primary care. Twelve questions covering: ocular symptoms (3 questions); vision-related function (6 questions); environmental triggers (3 questions). Score 0–100: 0–12 = normal; 13–22 = mild DED; 23–32 = moderate DED; >33 = severe DED. Use at every DED review to track treatment response. A reduction in OSDI score documents treatment efficacy and justifies continued prescription. OSDI is freely available (no licence required) and takes <2 minutes to complete. Alternative: the DEQ-5 (Dry Eye Questionnaire-5) — 5 questions; quicker; similar sensitivity.
BAK-free drops in contact lens wearersContact lens wearers with dry eye disease require specific management: (1) Drops MUST be preservative-free — BAK is absorbed by soft contact lens material and concentrates; released slowly onto the corneal surface causing toxicity. (2) Drops can be instilled while wearing lenses only if preservative-free — otherwise instil 15–30 minutes before lens insertion or after lens removal. (3) Sodium hyaluronate drops are particularly well tolerated with contact lens wear. (4) Contact lens wear itself worsens evaporative DED — lenses disrupt the tear film lipid layer; reduce corneal oxygen; absorb tear fluid. (5) Consider spectacle alternatives on very dry/symptomatic days. (6) Extended-wear or silicone hydrogel lenses have better oxygen transmissibility but do not eliminate DED. (7) Refer to optometrist for contact lens review if DED worsening with continued lens wear.
Ikervis (ciclosporin 0.1%): specialistIkervis (ciclosporin A cationic emulsion 0.1%) is a topical calcineurin inhibitor licensed in the UK for severe keratitis in adult patients with dry eye disease not adequately managed with preservative-free artificial tears (NICE TA369; 2014). Mechanism: inhibits T-cell-mediated inflammation at the ocular surface (DED has a significant inflammatory component). Dose: one drop in each affected eye once daily at bedtime. Licensed for: severe DED with keratitis (confirmed by slit lamp); must have failed adequate trial of PF lubricant tears. Side effects: transient stinging/burning on instillation (40% of patients); photophobia; initial worsening. GP role: be aware; ophthalmology/specialist initiates; can continue prescriptions in shared care after specialist assessment. Alternative: Restasis (ciclosporin 0.05% ophthalmic emulsion) — not currently licensed in UK for DED.
📋 Clinical Stem — Dry Eye Disorder
Mrs. Patricia Chen, 54, post-menopausal accountant, with 6 months of bilateral gritty; burning eyes — paradoxically also watering — exacerbated by prolonged screen use and contact lens wear, with antihistamine as a contributing medication
Mrs. Patricia Chen, 54, a post-menopausal accountant, presents with a 6-month history of bilateral gritty; burning; stinging eyes that have been getting progressively worse. She reports her eyes feel permanently dry, yet paradoxically also stream excessively, particularly in wind and air conditioning. She spends 8–10 hours per day on screens for work. She wears daily disposable contact lenses, which she now finds increasingly uncomfortable. She takes cetirizine 10mg OD for seasonal hay fever. She saw an optometrist 3 months ago who found no significant change in her prescription and advised artificial tears, but she is uncertain which ones to buy. She asks: “Can you give me something that will actually work — my eyes are driving me mad and I can’t wear my lenses properly anymore.”
This stem tests: the correct diagnosis of evaporative dry eye disease (MGD-driven; screen use; antihistamine contribution; contact lens exacerbation); explanation of the paradoxical epiphora; prescribing of preservative-free drops (not preserved, given frequency and contact lens use); lid hygiene advice (warm compresses + lid wipes as first-line for MGD); medication review (antihistamine); Sjögren’s screen if appropriate; and contact lens management advice.
Scenario A — Mrs. Chen (evaporative DED; screen use; contact lenses; antihistamine) Most common GP presentation. Evaporative type (MGD; screen use; antihistamine). Management: preservative-free sodium hyaluronate drops (Hylo-Forte ×4/day); warm compress BD + Blephasol lid wipes; 20-20-20 rule; antihistamine review; contact lens advice; consider omega-3. Review 6–8 weeks. Sjögren’s screen not required today (no dry mouth; no systemic features).
Scenario B — Sjögren’s screen Dry eyes + dry mouth (xerostomia) + joint pains + fatigue. Aqueous-deficient type. Schirmer’s <5mm/5min. Anti-Ro; anti-La; ANA; FBC; ESR; CRP; Ig; salivary gland USS. Refer: rheumatology + ophthalmology + oral medicine. Sjögren’s: significantly increased lymphoma risk (long-term monitoring). Lubricant drops: high frequency PF; consider Ikervis if keratitis. Hydroxychloroquine for systemic symptoms (rheumatology).
Scenario C — Medication-induced DED Patient on: antihistamines; TCAs; SSRIs; antipsychotics; beta-blockers; diuretics; isotretinoin; OCP; anti-glaucoma drops (BAK preservative). Review contributing medications. Switch to non-anticholinergic antihistamine (loratadine preferred over cetirizine if anticholinergic contribution is concern) or intranasal corticosteroid alternative. Stop or reduce contributing drug where clinically appropriate. Anti-glaucoma drops with BAK: switch to preservative-free formulation or BAK-free alternative.
Scenario D — Post-LASIK dry eye LASIK surgery severs corneal nerves → reduced blink reflex → severe DED. Can last 1–2 years. Intensive PF lubricant drops; preservative-free gels; punctal plugs (ophthalmology); Ikervis if keratitis. Avoid preserved drops (post-surgical cornea is more vulnerable to BAK toxicity). Ophthalmology review at 6–12 weeks post-LASIK standard.
Scenario E — Severe/refractory DED (referral scenario) OSDI >33 despite optimal step 1–2 treatment; keratitis on slit lamp; reduced vision. Ophthalmology referral: slit lamp examination; TBUT; Schirmer’s; meibography; Ikervis if keratitis; punctal plugs; scleral contact lenses; autologous serum drops; moisture chamber spectacles. GP role: optimise all reversible factors before referral (medication review; lid hygiene; PF drops compliance); document OSDI at referral.
Key variables to adapt for Type (evaporative [MGD; screen use; contact lenses] vs aqueous-deficient [Sjögren’s; post-radiation; age]); severity (OSDI score; visual impact; contact lens ability); medication contributions (antihistamines; TCAs; SSRIs; anti-glaucoma drops with BAK); systemic disease (Sjögren’s; RA; lupus; thyroid; rosacea; Parkinson’s); contact lens wear (always PF drops; timing advice); post-surgical (LASIK; intense PF; ophthalmology); menopausal status (oestrogen deficiency worsens MGD); occupational screen exposure
Steps:
1
Step 1
History — Symptom Character · Triggers · Screen Exposure · Medication Review · Sjögren’s Screen · Contact Lens History
collapse
The history in dry eye disease establishes the type (evaporative vs aqueous-deficient); identifies modifiable triggers (screen use; medications; contact lenses); screens for systemic causes (Sjögren’s; RA; thyroid); and identifies whether the “watery” eyes the patient reports are paradoxical epiphora (reflex tearing from DED) rather than over-production or allergy. Mrs. Chen has four identifiable drivers: prolonged screen use; daily contact lens wear; antihistamine use; and post-menopausal oestrogen deficiency.
🎓 SCA opener — acknowledge the frustration before exploring the history
"It sounds like this has been really interfering with your work and your daily life — dry, streaming eyes all day at a screen must be exhausting. Tell me more about when it started and what makes it worse."
Mrs. Chen is frustrated. She has seen an optometrist who gave vague advice, and she wants something concrete. The opener acknowledges the occupational impact (accounting; screens; contact lenses) and invites her to describe the full symptom picture — which will reveal the paradoxical epiphora and the full trigger list.
1A — Open question, then targeted dry eye history
QuestionWhy it mattersChanges what?
🏲 OPEN QUESTION"Tell me more about what the eyes have been like — when it started; what the symptoms feel like; and what makes them worse or better."The open question reveals: the full symptom constellation (gritty; burning; stinging; watering; blurred); the temporal pattern (worse later in the day = reduced blink accumulation over time; worse in specific environments = evaporative type); the functional impact (contact lens intolerance; screen use difficulties; driving). It also surfaces the paradoxical epiphora — the “streaming eyes” which need to be explained as reflex tearing from dry eye rather than over-production or allergy.SCA: Global Skills; patient-led consultation; functional impact emerges naturallyType (evaporative vs aqueous); temporal pattern; triggers; functional impact; paradoxical epiphora
Screen exposure history"How many hours a day are you on screens for work? Do you notice the eyes worse after screen use?"Mrs. Chen: 8–10 hours/day on screens. Prolonged screen use reduces blink rate from 12–15 blinks/minute to 3–8 blinks/minute — each blink spreads and renews the tear film; reduced blinking = accelerated evaporation = DED. This is the most immediately modifiable trigger. The 20-20-20 rule (every 20 minutes; look 20 feet away; for 20 seconds) is the primary lifestyle intervention. Screen position below eye level reduces exposed ocular surface area. This history directly drives lifestyle advice.Screen use identified: 20-20-20 rule; screen position below eye level; font size increase; regular breaks; reminders; humidifier at workstation
Contact lens history"What type of lenses do you wear? How many hours/day? Are the symptoms worse with lenses in?"Daily disposable contact lenses. Contact lens wear worsens evaporative DED: lenses disrupt the tear film lipid layer; reduce corneal oxygen supply; absorb tear fluid from the surface. This creates a two-pronged problem: worsening the DED and reducing the patient’s ability to wear lenses. Key prescribing implication: all eye drops for contact lens wearers must be preservative-free (BAK absorbed into lens material; concentrates; released onto cornea). Drops can be instilled while wearing lenses ONLY if preservative-free; otherwise 15–30 min before insertion or after removal.Contact lens: always prescribe PF drops; timing advice (PF = in lenses; otherwise 15-30 min gap); consider spectacle alternatives on bad days; review with optometrist
Medication history — dry eye drug culprits"Tell me all the medications you take — including over-the-counter. Antihistamines? Any eye drops?"Mrs. Chen takes cetirizine 10mg OD. Antihistamines are anticholinergic — they reduce lacrimal gland secretion and worsen aqueous-deficient DED. Other key offenders: TCAs (amitriptyline); SSRIs; antipsychotics; beta-blockers; diuretics; isotretinoin; OCP/HRT; anti-glaucoma drops (BAK preservative). Management: discuss modification of antihistamine if DED is driving quality of life impact. Options: loratadine (less anticholinergic than cetirizine — small difference; consider); intranasal corticosteroid (fluticasone nasal spray) instead of oral antihistamine; allergen immunotherapy if hay fever is severe. BAK-containing anti-glaucoma drops: switch to BAK-free formulation (latanoprost PF; travoprost PF).Antihistamine: discuss switch to intranasal corticosteroid; loratadine; or allergen immunotherapy. BAK anti-glaucoma drops: PF formulation switch
Dry mouth and systemic features — Sjögren’s screen"Do you also have a dry mouth? Any difficulty swallowing dry foods? Dry skin; joint pains; fatigue; swollen glands? Any known autoimmune conditions?"Sjögren’s syndrome presents with sicca features (dry eyes + dry mouth). Mrs. Chen: post-menopausal — dry mouth is common post-menopause; distinguish from Sjögren’s by associated features (systemic symptoms; autoimmune history). Screen for Sjögren’s if: dry eyes + dry mouth + systemic features (joint pains; fatigue; parotid swelling; Raynaud’s). Sjögren’s has significantly increased lymphoma risk (40–60×) — important long-term monitoring consequence. If Sjögren’s suspected: anti-Ro (SS-A); anti-La (SS-B); ANA; RF; FBC; ESR; CRP; Ig; salivary gland USS; refer rheumatology.Sjögren’s features: anti-Ro; anti-La; ANA; RF; FBC; ESR; CRP; salivary USS; rheumatology referral. Mrs. Chen: no dry mouth — screen not required today but document
Environmental and occupational triggers"Does it get worse in air conditioning? Low humidity? Wind? Outdoors? What is your work environment like?"Environmental triggers of evaporative DED: air conditioning; heating; low humidity; wind; high altitude; cigarette smoke; overhead fans. All reduce ambient humidity and accelerate tear evaporation. Mrs. Chen works in an air-conditioned office — direct trigger. Interventions: desk humidifier; reduce direct air conditioning airflow; position screen below eye level (reduces exposed surface area); wraparound glasses/moisture chambers in wind outdoors.Air conditioning/low humidity: desk humidifier; reduce AC direct flow; wraparound glasses outdoors; screen position; omega-3 supplementation (modest anti-inflammatory benefit)
1B — Red flags
🚨

Red Flags — eye symptoms requiring urgent action

Red flagWhy dangerousAction
Sudden visual loss; monocularRetinal artery occlusion; acute angle-closure glaucoma; retinal detachment. Dry eye does NOT cause acute visual loss. New or sudden visual loss in any context = urgent ophthalmology.999 or same-day ophthalmology
Red painful eye + haloes around lightsAcute angle-closure glaucoma (AACG). Medical emergency: IOP >40mmHg; permanent visual loss within hours if untreated. Nausea; vomiting; coloured haloes; rock-hard eye. 999.999 — acute ophthalmology; IV acetazolamide; laser iridotomy
Severe pain; photophobia; purulent discharge; contact lens wearerBacterial or Acanthamoeba keratitis — vision-threatening. Contact lens wearers are at particularly high risk of Acanthamoeba keratitis (especially with tap water lens rinsing; swimming). Corneal ulceration can perforate within days. Same-day ophthalmology emergency.Same-day ophthalmology — corneal scraping; cultures; intensive topical antibiotics
Corneal clouding; white opacityCorneal ulceration (infectious keratitis; severe DED with corneal erosion; neurotrophic keratitis). Dry eye-related corneal erosion can progress to perforation in severe cases without treatment.Same-day ophthalmology
Dry eyes + dry mouth + systemic features (joint pains; fatigue; parotid swelling)Sjögren’s syndrome. Significantly increased lymphoma risk (40–60× general population). Systemic involvement (renal; pulmonary; neurological; cardiovascular). Requires rheumatology review and long-term monitoring.Urgent bloods (anti-Ro; anti-La; ANA); rheumatology referral
🛡️

Safeguarding — Dry Eye and Vulnerability

Severe dry eye disease causes significant occupational and functional impairment. Mrs. Chen’s ability to work as an accountant is directly affected by her screen intolerance. Untreated or inadequately treated DED can lead to: inability to drive (blurred vision; photophobia); loss of employment (screen intolerance); significant reduction in quality of life (chronic pain; social restriction). Sjögren’s syndrome — if diagnosed — requires specific safeguarding regarding lymphoma risk and systemic organ involvement.
💼 Occupational safeguarding
  • Screen intolerance threatening employment — document impact on ability to work
  • Workplace adjustments: display screen equipment (DSE) assessment; anti-glare screen; lighting adjustment; humidifier — employer legal obligation under Health and Safety (Display Screen Equipment) Regulations 1992
  • Ophthalmology referral to support reasonable adjustment documentation if needed
  • Contact lens intolerance: optometrist review; spectacle alternative; Equality Act implications if related to disability
🚘 Driving safety
  • Severe DED with blurred vision or photophobia: driving safety must be discussed
  • DVLA: drivers must notify if vision does not meet the required standard — most DED patients will not reach DVLA threshold
  • Practical advice: instil lubricant drops before driving; avoid driving in low-humidity conditions without treatment; use moisture chamber glasses
🥑 Sjögren’s and systemic risk
  • If Sjögren’s diagnosed: lymphoma risk (40–60×); document and institute monitoring
  • Annual FBC and LDH for lymphoma surveillance in Sjögren’s
  • Systemic organ involvement: renal; pulmonary; neurological — co-ordinate specialist monitoring with rheumatology
💋 Medication safety
  • Contact lens wearers receiving preserved eye drops: BAK toxicity risk — must prescribe preservative-free
  • Document medication contribution to DED (antihistamine; antidepressant; OCP) to allow future clinical decisions to consider DED as a known side effect
  • BAK-containing anti-glaucoma drops: patient safety issue — switch to PF formulation where available; document if switch not possible and why
Actions: DSE workplace assessment recommended; ophthalmology referral if vision impairment threatening work or driving; Sjögren’s screen if systemic features; PF drops prescribed (contact lens wearer + likely >4×/day use); antihistamine modification discussed.
1C — PMH · Drug history · Social history
🥐 PMH · Systemic causes of DED
FactorWhy it mattersImpact
Post-menopausal statusOestrogen and androgens both influence meibomian gland function and tear production. Post-menopausal oestrogen deficiency worsens evaporative DED — meibomian gland secretion is androgen-dependent; post-menopausal women have reduced androgen levels. This is a major reason DED is significantly more common in post-menopausal women. HRT (oestrogen-only or combined): evidence mixed but some evidence of benefit for DED symptoms in post-menopausal women — discuss if also indicated for other menopausal symptoms.Post-menopausal DED: consider HRT discussion if other menopausal symptoms present; androgen-containing eye drops (investigational); emphasise lid hygiene for MGD
RosaceaOcular rosacea is a common and underdiagnosed cause of evaporative DED and blepharitis. Rosacea affects the meibomian glands directly — classic presentation: blepharitis; lid telangiectasia; capped meibomian glands; chronic dry eye. Treatment: lid hygiene; doxycycline 40mg modified-release (low-dose; anti-inflammatory; not antimicrobial at this dose) reduces meibomian gland inflammation and improves DED in rosacea patients.Rosacea + DED: doxycycline 40mg MR OD (Efracea); intensive lid hygiene; oral omega-3; azithromycin if doxycycline not tolerated
Thyroid eye diseaseGraves’ orbitopathy (thyroid eye disease; TED) causes exophthalmos — proptosis increases exposed ocular surface area and accelerates evaporation; lagophthalmos (incomplete lid closure) causes exposure keratopathy. Management: PF lubricant drops; ointment at night (prevents corneal drying during sleep); lid taping; ophthalmology urgent referral if corneal exposure.TED with exposure: urgent ophthalmology; PF drops; VitA-POS ointment at night; taping if lagophthalmos
💊 Drug history · Key DED offenders
DrugMechanism of DEDManagement
Antihistamines (Mrs. Chen: cetirizine)Anticholinergic effect → reduced lacrimal secretion; reduced conjunctival goblet cell function. All antihistamines can worsen DED; first-generation (chlorphenamine) worse than second-generation (cetirizine; loratadine). Even second-generation have some anticholinergic effect.Switch to intranasal corticosteroid (fluticasone nasal spray — first-line for allergic rhinitis; no anticholinergic effect); loratadine (marginally less anticholinergic). Allergen immunotherapy if hay fever severe.
Antidepressants (TCAs; SSRIs; SNRIs)TCAs (amitriptyline; nortriptyline): potent anticholinergic; reduce tear secretion significantly. SSRIs: less anticholinergic but can cause DED. SNRIs: via anticholinergic and sympathetic effects. Do not stop without clinical review — DED from antidepressants managed with intensive lubricant eye drops alongside the antidepressant.PF lubricant drops ×4–6/day alongside antidepressant; do not stop antidepressant for DED alone; discuss with prescriber if DED is severe
BAK-preserved anti-glaucoma dropsBenzalkonium chloride in glaucoma drops (latanoprost; timolol; dorzolamide; brimonidine): direct toxic effect on corneal epithelium and meibomian glands; amplifies DED. Patients on multiple BAK-containing glaucoma drops have the most severe drug-induced DED.Switch to PF glaucoma drops where available (latanoprost PF — Monopost; travoprost PF — DuoTrav PF; bimatoprost PF — Lumigan PF); fixed-combination PF drops; discuss with ophthalmologist
OCP / HRT (oestrogen)Oral oestrogen (OCP; some HRT) may worsen DED by increasing sex hormone-binding globulin and reducing bioavailable androgens — reduces meibomian gland function. Transdermal oestrogen (patches; gel) does not have this effect via SHBG mechanism and is preferred in women with DED and menopausal symptoms.Consider transdermal HRT (gel; patch) instead of oral if HRT indicated; discuss with gynaecology or primary care menopause specialist
1D — ICE
💡 Ideas
"What do you think is causing the eye problems? Have you any idea why they have got worse recently?"
Mrs. Chen may link the worsening to her screen use (correct); her contact lenses (correct); or simply to aging (partially correct — post-menopausal status). She may not have identified the antihistamine as a contributor (likely incorrect attribution). Understanding her illness model allows the GP to validate what is correct (screens; lenses; age) and add what she has not identified (antihistamine; air conditioning; lid margin disease). It also opens the conversation about what she can change (screen habits; antihistamine; humidifier) vs what is harder to change (post-menopausal status; contact lens need).
😟 Concerns
"What worries you most about the eye symptoms? Are you concerned it could be something more serious — or that your vision might be affected long-term?"
Many patients with DED are worried about permanent visual damage. The reassurance is specific: “Dry eye is very common; very manageable; and rarely causes permanent vision problems when treated. The discomfort you are experiencing is very real but your vision itself is not under threat.” If there are any signs of keratitis (corneal staining; vision change): this reassurance is modified and ophthalmology referral is appropriate. Identifying the vision concern prevents unnecessary worry and focuses the consultation on management.
🎯 Expectations
"What were you hoping I could give you today? You mentioned wanting something that actually works — has the optometrist’s advice not been helpful?"
Mrs. Chen wants drops that work. She has tried OTC lubricants which have been inadequate. She needs: specific prescription recommendations (preservative-free sodium hyaluronate — more effective than basic OTC drops); education about why the drops she was using may not have been working (preserved; not enough frequency; wrong type for her tear deficiency type); and the additional interventions (lid hygiene; antihistamine review; screen habits) that the optometrist may not have discussed. Her expectation is achievable — with the right combination of treatments, most patients with DED like Mrs. Chen get significant improvement.
1E — Psychosocial context
🧑️ Dry eye disease is a chronic condition with significant occupational and quality-of-life impact — Mrs. Chen’s entire working life depends on her ability to use screens comfortably

Chronic dry eye causes fatigue; difficulty concentrating; impaired work performance; and significant emotional distress. For a 54-year-old accountant at peak career responsibility, screen intolerance threatens professional function. Contact lens intolerance removes a personal preference and may affect professional appearance and confidence. The management plan must address these dimensions directly.

💼 Occupational Impact

8–10 hours/day on screens. DED is now a functional occupational disability. DSE workplace assessment (employer obligation). Anti-glare screen; lighting adjustment; humidifier; screen position below eye level. OSDI documentation supports reasonable adjustment requests.

"As an accountant you are essentially required to be at a screen all day. That means we need to make your workplace as DED-friendly as possible — I am going to go through the specific changes that will make a real difference."
👤 Contact Lens Frustration

Daily lenses increasingly uncomfortable. This directly affects daily life and professional appearance. Management: preservative-free drops in or around lens use; spectacle alternatives on symptomatic days; optometrist review (different lens material; daily disposable vs extended; silicone hydrogel). Reassure: managing DED effectively usually allows lenses to be tolerated again.

"Getting the dry eye under control should help significantly with your lens comfort. In the meantime, let’s make sure the drops you are using are safe to use with lenses in."
💕 Menopausal Context

Post-menopausal — DED is significantly more common post-menopause (oestrogen and androgen deficiency affecting meibomian glands and lacrimal secretion). If other menopausal symptoms are present: HRT discussion is appropriate — transdermal oestrogen may benefit DED alongside menopausal symptoms. This is also an opportunity for holistic menopausal health review.

"I should mention that the menopause does contribute to dry eye — it is very common in women your age. Are you experiencing any other menopausal symptoms? Because there may be a treatment that could help both."
📈 Prognosis and Realistic Hope

DED is a chronic condition — management not cure for most patients. However: Mrs. Chen has multiple identifiable and modifiable triggers. With optimal management (PF drops + lid hygiene + antihistamine review + screen habits + humidifier), most patients with evaporative DED of this type get significant improvement within 4–8 weeks. Realistic optimism: “This is very manageable — and we have a clear action plan.”

"Dry eye is chronic but very manageable. With the right drops; the lid hygiene routine; and the screen changes — you should see real improvement within 4–8 weeks."
🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills
Key phrases
"The watering eyes — I want to explain that. It sounds like the opposite of dry eye, doesn’t it? But actually, the dryness irritates the surface of the eye, which triggers a reflex that floods the eye with low-quality tears — those wash away quickly and leave the surface dry again. So the streaming is a symptom of the dryness, not a separate problem."
"Your antihistamine may be making the dry eye worse — it has a mild drying effect on the eye surface. I want to talk about whether there is an alternative that would control your hay fever without that effect."
Deductions
  • Not explaining paradoxical epiphora — Mrs. Chen is confused about “dry but watery” eyes; not addressing this leaves her without a coherent explanation and reduces adherence to DED treatment
  • Not identifying antihistamine as a contributing factor — a modifiable trigger not identified = incomplete management
🔴 Red
Paradoxical epiphora not explained; antihistamine not identified; preserved drops prescribed (contact lens wearer); screen exposure not addressed; Sjögren’s not screened for; lid hygiene not mentioned; no OSDI; no 20-20-20 rule
🟠 Amber
PF drops prescribed; screen advice given; lid hygiene mentioned; antihistamine identified; epiphora explained; no OSDI; Sjögren’s not screened; omega-3 not discussed; 6–8 week review not booked
🟩 Green
Occupational impact acknowledged; paradoxical epiphora explained; antihistamine identified + modification discussed; PF sodium hyaluronate drops; lid hygiene (warm compress + Blephasol); 20-20-20 rule; humidifier; contact lens advice; OSDI administered; Sjögren’s screened (no features today); 6–8 week review; omega-3 discussed; closing question
2
Step 2
Triage — Vision-Threatening Emergency · Urgent (Sjögren’s; Keratitis) · GP-Managed DED
collapse
The triage question: vision-threatening emergency (AACG; keratitis; sudden visual loss); urgent (Sjögren’s screen; keratitis in contact lens wearer); or GP-managed DED? Mrs. Chen: no emergency features; evaporative DED — GP-managed with stepwise treatment.
🔴 Emergency

999 / Same-Day Ophthalmology

Immediate
  • Acute angle-closure glaucomaRed eye; haloes; severe pain; nausea — 999; IV acetazolamide; laser iridotomy
  • Sudden visual lossRetinal artery occlusion; retinal detachment — 999 / same-day ophthalmology
  • Keratitis (contact lens wearer; severe pain; purulent)Same-day ophthalmology; corneal scraping; intensive topical antibiotics
🟠 Urgent

Urgent Ophthalmology or Rheumatology

Days–2 weeks
  • Sjögren’s features (dry mouth + systemic)Anti-Ro; anti-La; ANA; urgent rheumatology
  • Vision-impacting DED not responding to primary care treatmentOphthalmology; OSDI >33; corneal staining; Ikervis consideration
🟩 GP-managed — Mrs. Chen

Stepwise Primary Care Treatment

NICE CKS stepwise
  • Evaporative DED; OSDI moderate; contact lens wearerPF sodium hyaluronate drops; warm compress + lid hygiene; 20-20-20; antihistamine review; omega-3; 6–8 week review
  • Mild DED without systemic featuresPatient education; preserved lubricant drops PRN; lid hygiene; screen habits
🎓 SCA Checkpoint — Step 2Tasks
Emergency exclusion
"Before we go further — I want to check: have you had any sudden change in your vision? Any severe pain or headache with the eye? Any redness with haloes around lights? And are you well in yourself — no dry mouth; no joint pains or fatigue alongside the eye symptoms?"
Deductions
  • Not asking about acute angle-closure glaucoma features (haloes; severe pain) — a missed AACG in a 54-year-old post-menopausal woman with eye symptoms = serious patient safety error
3
Step 3
Examination — Lid Margins · MGD Signs · Conjunctiva · Corneal Surface
collapse
Examine the lid margins (MGD signs); conjunctiva; and corneal surface. Note: slit-lamp examination and fluorescein staining are usually performed by optometrists and ophthalmologists — the GP examination establishes the type of DED and identifies red flags for referral.
ExaminationWhat it showsManagement impactChanges?
Lid margin inspectionErythema; telangiectasia; thickening; meibomian gland orifice cappingMGD signs: lid margin erythema; telangiectasia at lid margins; thickened posterior lid margins; capping of meibomian gland orifices (plugs of dried meibum — appear as white dots along lid margin). Meibum expression (gentle pressure along lid margin): normal meibum = clear oily secretion; MGD = turbid; thickened; or absent secretion. MGD confirms evaporative type — the most common. Treatment: warm compresses + lid massage + lid wipes — first-line; essential for MGD.MGD confirmed: warm compress + lid massage + Blephasol BD — as important as drops for evaporative DED. No MGD: aqueous-deficient type more likely; Sjögren’s screenYES — type determines treatment: MGD = lid hygiene first-line; aqueous-deficient = Sjögren’s screen; high-frequency PF drops
Conjunctival examinationInjection; chemosis; conjunctival chalasisConjunctival injection (redness) in DED: usually mild diffuse; worse inferiorly. Conjunctival chalasis: folds of conjunctiva that can block meibomian gland orifices (ophthalmology). Distinguish from: allergic conjunctivitis (papillae; seasonal; discharge; itching dominant over dryness); bacterial conjunctivitis (mucopurulent discharge; lids stuck on waking); viral conjunctivitis (watery; lymphadenopathy; preauricular node). Mrs. Chen: if predominantly dry/gritty with no discharge and no itching = DED more likely than allergic.Conjunctival injection without discharge or significant itching: supports DED. Discharge: consider infective. Papillae + itching: allergic conjunctivitis — treat rhinitis+eyes separatelyYES — allergic vs DED vs infective distinction
Visual acuity (Snellen)Visual acuity in DED: usually normal or mildly fluctuating (blurred vision that improves after blinking is characteristic — blink restores the tear film briefly). Significant stable VA reduction: refer to ophthalmology — consider other diagnoses (cataract; macular disease; glaucoma). VA at referral to ophthalmology provides an important baseline.VA reduced and not corrected by blinking: ophthalmology referral. VA normal or transiently blurred with blinking: consistent with DED; continue managementYES — persistent VA reduction = ophthalmology; fluctuating = DED
Corneal surface — if availableFluorescein staining (optometrist; ophthalmology); irregularity visible with torch in severe DEDGP cannot perform slit-lamp examination or fluorescein staining. Optometrist/ophthalmologist examination: TBUT (tear break-up time; <10s = abnormal; <5s = severe); fluorescein staining (punctate epithelial erosions; staining pattern helps classify DED type); rose Bengal or lissamine green staining (dead/damaged cells — conjunctival and corneal damage from DED); Schirmer’s test (<5mm/5min = severe aqueous-deficient DED). For the GP: refer if Mrs. Chen has not had recent optometric assessment or if symptoms not responding to first-line treatment.GP: assess TBUT data from optometrist; refer for OSDI + slit lamp if diagnosis unclear or treatment failing. Ophthalmology: Ikervis if keratitis confirmed on slit lampYES — keratitis on slit lamp: Ikervis; ophthalmology follow-up
🎓 SCA Checkpoint — Step 3Tasks
Lid margin examination
"I want to look specifically at your eyelids — at the edges of the lids where the oil glands are. Those glands are often the main problem in the type of dry eye that comes on with screen use. I am also going to check your vision and look at the white part of the eye."
Deductions
  • Not examining lid margins — MGD is the most common type of DED (∼85%); lid margin examination identifies it and confirms the first-line treatment is lid hygiene + warm compress; not just drops
4
Step 4
Investigations — OSDI Score · Sjögren’s Screen · Optometrist Data
collapse
Most DED does not require investigation — it is a clinical diagnosis. Investigations are triggered by: suspected Sjögren’s; failure to respond to first-line treatment; or suspected systemic disease contributing to DED. The OSDI questionnaire should be completed at every DED consultation.
InvestigationWhen and whyResult and action
OSDI (Ocular Surface Disease Index) — at every consultation12 questions; 0–100; validate severity; track treatment responseOSDI is the NICE CKS-recommended validated patient-reported outcome measure for DED. Twelve questions covering: symptoms (itching; pain; blurred vision; poor vision); functional impact (reading; driving; working on computer; watching TV); environmental triggers (wind; low humidity; air conditioning). Score 0–100: 0–12 normal; 13–22 mild; 23–32 moderate; >33 severe. Use at first consultation (baseline) and at 6–8 week review (treatment response). A reduction of ≥7 points is clinically meaningful. For Mrs. Chen: OSDI at baseline establishes severity and documents functional occupational impact (supports workplace adjustment requests).OSDI 0–22: conservative management; lifestyle; preserved drops PRN. OSDI 23–32: PF drops regularly ×4/day; lid hygiene; medication review; 6–8 week review. OSDI >33: PF drops ×6–8/day; ophthalmology referral if failing step 1–2 treatment.
Sjögren’s screen — if dry eyes + dry mouth + systemic featuresAnti-Ro (SS-A); anti-La (SS-B); ANA; RF; FBC; ESR; CRP; immunoglobulinsIndicated if: dry eyes + dry mouth (ask specifically at every DED consultation); systemic features (joint pains; parotid swelling; fatigue; Raynaud’s). Mrs. Chen: no dry mouth; no systemic features — screen not required today (document as screened and not indicated). If Sjögren’s features emerge: anti-Ro most sensitive; anti-La more specific; ANA; RF. Additional: FBC (lymphopenia); complement (C3/C4; low in active disease); salivary gland USS (enlargement; heterogeneous echotexture). Lip biopsy: gold standard (focal lymphocytic sialadenitis) — specialist decision.Anti-Ro positive (with symptoms): refer rheumatology + ophthalmology. Negative with strong clinical suspicion: refer rheumatology for further investigation including lip biopsy. Document Sjögren’s screen as considered at this consultation even if not performed.
Optometrist TBUT and Schirmer’s data — request letter/review findingsTBUT <10s = abnormal; <5s = severe. Schirmer’s <5mm/5min = severe aqueous-deficient DEDMrs. Chen saw an optometrist 3 months ago — request the letter/report. TBUT (tear break-up time): normal >10 seconds; <10 = DED; <5 = severe evaporative type. Measured with fluorescein and slit lamp. Schirmer’s test: filter paper inserted into lower fornix for 5 minutes; <5mm = severe aqueous-deficient DED (Sjögren’s; post-radiation; age-related lacrimal insufficiency). Meibography (imaging of meibomian glands): optometrist/ophthalmology; identifies gland dropout; guides MGD treatment intensity.TBUT <5s + Schirmer’s >5mm: evaporative (MGD-driven) — lid hygiene first-line. Schirmer’s <5mm: aqueous-deficient — Sjögren’s screen; high-frequency PF drops; ophthalmology referral. Both abnormal: mixed DED.
Thyroid function tests — if proptosis; lid retraction; bilateral DED in womanTSH; free T4; TSH receptor antibodies (TRAb); orbital USSThyroid eye disease (Graves’ orbitopathy): bilateral proptosis; lid retraction; injection; periorbital oedema — causes exposure keratopathy (DED from incomplete lid closure). TSH; fT4; TRAb (thyroid receptor antibodies — specific for Graves’ disease even if euthyroid). Orbital USS: orbital fat swelling; muscle thickening. Urgent ophthalmology if sight-threatening (corneal exposure; optic nerve compression).Thyroid eye disease: urgent ophthalmology; PF lubricant drops; ointment at night (VitA-POS); selenium supplementation (mild TED); IV methylprednisolone + orbital radiotherapy (moderate-severe TED; ophthalmology).
🎓 SCA Checkpoint — Step 4Tasks
OSDI and investigations
"I want to use a quick questionnaire — it asks about how your eyes have been affecting your daily life. There are 12 questions and it takes about 2 minutes. This helps me track whether the treatment is working when we see you again."
"I also want to ask specifically — have you had any problems with a dry mouth; difficulty swallowing dry food; or any joint pains? I ask because sometimes dry eyes and dry mouth go together as part of a condition I need to screen for."
Deductions
  • Not asking about dry mouth — Sjögren’s sicca screen is a mandatory component of the DED history; missing it means a systemic condition with significant lymphoma risk could be missed
5
Step 5
Diagnosis — Evaporative DED · Plain Language · Paradoxical Epiphora Explained · DDx
collapse
The diagnosis communication must explain the paradoxical epiphora (the most counterintuitive feature); address the “why me, why now” question; and set up the treatment explanation.
🗣️ Explaining dry eye disease — including the paradox of watery eyes

"You have dry eye disease — which I know sounds like a strange diagnosis when your eyes are also streaming. Let me explain why both happen at the same time. Your eyes have several layers of tears — a watery layer; an oily outer layer from glands along your eyelids; and a sticky inner layer. In your case the oily layer — from glands called meibomian glands — is not working as well as it should. That means your tears evaporate too quickly and the surface of your eye gets irritated. When the surface gets irritated, your eye has an emergency reflex: it floods the eye with a sudden burst of watery tears. But these reflex tears are low quality — they lack the oily layer — so they wash away almost immediately and the surface gets dry again. That is why you get the gritty feeling AND the streaming — they are two sides of the same problem. The good news is that we have a very clear idea of what is driving this for you: the prolonged screen use reducing your blink rate; your contact lenses; your hay fever tablet; and the air conditioning at work. And all of those are things we can address."

💬 Addressing key concerns

"Could this damage my eyes permanently? Will my vision be affected?"
"Dry eye is uncomfortable but rarely causes permanent vision damage when it is treated appropriately. Your vision is not under threat. What we want to avoid is leaving it untreated — because ongoing ocular surface inflammation, if untreated, can over time affect the corneal surface. But with the treatment plan I am going to describe, that risk is very low."

"Why have I got it now and not before?"
"Three things have probably converged: the menopause changes the oil glands in your eyelids — they are affected by hormone levels; your screen use has likely increased; and the antihistamine you take for hay fever has a mild drying effect on the eye surface. It is the combination that has tipped you over the threshold."

Mrs. Chen’s Diagnosis
GP-managed; stepwise
Evaporative DED (MGD-driven); 6 months; bilateral; gritty; burning; paradoxical epiphora; screen use 8–10h/day; daily disposable contact lenses; cetirizine antihistamine; post-menopausal; air-conditioned office. OSDI [score at consultation]. No systemic features (Sjögren’s screened; not suspected). Management: PF sodium hyaluronate drops ×4/day; warm compress + Blephasol BD; 20-20-20 rule; antihistamine review; omega-3; 6–8 week review.
Differential — Consider

Allergic conjunctivitis

Itching dominant; papillae; seasonal; discharge; responds to antihistamine drops. Mrs. Chen: gritty + burning dominant (not itch); no discharge — DED more likely; may coexist.

Blepharitis without DED

Anterior blepharitis (lid margin crusting; collarettes; Staphylococcal or seborrhoeic) — often with DED. Treat blepharitis with lid hygiene; may need topical antibiotic if bacterial. Posterior blepharitis = MGD.

Do Not Miss

Sjögren’s syndrome

Dry eyes + dry mouth + systemic features. Screened today: no features in Mrs. Chen. Anti-Ro; anti-La; ANA if features emerge.

Acute angle-closure glaucoma

Red painful eye + haloes + nausea. Emergency. Excluded today — no acute pain; no haloes.

📊 DED severity and treatment step
OSDISeverityFirst-lineEscalate?
0–12Normal / asymptomaticLifestyle advice only; preserved drops PRN; screen habitsNo
13–22Mild DEDPreserved lubricant drops ×3–4/day; lid hygiene; 20-20-20; medication review; 8-week reviewIf not improving at 8 weeks: switch to PF drops; optometrist review
23–32 (Mrs. Chen)Moderate DEDPF sodium hyaluronate ×4/day; warm compress BD + Blephasol; antihistamine review; omega-3; humidifier; contact lens advice; 6–8 week reviewNot improving at 6–8 weeks: ophthalmology referral; carbomer gel at night; Ikervis if keratitis
>33Severe DEDPF drops ×6–8/day; carbomer gel at night; ophthalmology referral; all step 1–2 measures maximisedOphthalmology: Ikervis; punctal plugs; autologous serum; scleral lenses; moisture chambers
🎓 SCA Checkpoint — Step 5TasksRelating to Others
Paradoxical epiphora explanation
"The watery eyes — let me explain that, because I know it seems like the opposite of dry eye. The dryness irritates the surface of the eye, which triggers a reflex that floods the eye with a sudden burst of watery tears — but these reflex tears lack the oily layer that makes tears stable, so they wash away almost immediately and the surface is dry again. So the streaming you experience is actually a symptom of the dryness — not a separate problem."
Deductions
  • Not explaining paradoxical epiphora — Mrs. Chen’s chief confusion is “dry but watery”; without this explanation she cannot make sense of the diagnosis and will struggle to trust the treatment plan
6
Step 6
Referral — Ophthalmology · Optometrist · Rheumatology (Sjögren’s)
collapse
Most DED is GP-managed. Ophthalmology referral is triggered by: treatment failure at 6–8 weeks; OSDI >33; suspected keratitis; Sjögren’s; thyroid eye disease; or contact lens-related keratitis emergency.
ReferralUrgencyGP actions firstMust NOT do
Ophthalmology — if failing step 1–2 at 6–8 weeks; OSDI >33; keratitisRoutine — if failing treatment; urgent if keratitis or vision-threateningMaximise all reversible factors before referral: PF drops ×4/day; lid hygiene BD; antihistamine modified; omega-3; screen habits; humidifier. Include in referral: OSDI baseline and at review; optometrist TBUT/Schirmer’s data; medications (antihistamine; any BAK drops); contact lens details; systemic history (post-menopausal; rosacea; autoimmune). Ophthalmology will: slit lamp + fluorescein staining; meibography; consider Ikervis if keratitis; punctal plugs; autologous serum; specialist MGD treatments (IPL; thermal pulsation). For Mrs. Chen: not indicated today — plan if no improvement at 6–8 weeks.Do NOT refer before adequate trial of first-line treatment (minimum 6–8 weeks of PF drops + lid hygiene + medication review). Do NOT prescribe Ikervis (ciclosporin 0.1%) without ophthalmology assessment confirming keratitis — specialist initiation only.
Optometrist review — contact lens assessment; TBUT; meibographyRoutine — contact lens wearers with worsening DEDMrs. Chen: already seen optometrist 3 months ago. Re-refer if: contact lens intolerance worsening; lens type needs changing (silicone hydrogel; shorter wear duration); TBUT and Schirmer’s data needed for management. Optometrist can perform: TBUT; Schirmer’s; fluorescein staining; meibography; advise on contact lens type and schedule; MGD treatment (LipiFlow; intense pulsed light — specialist optometry practices).Do NOT advise Mrs. Chen to “stop her contact lenses permanently” without specialist assessment — with DED management many patients can continue lens wear. Optometrist will advise on specific lens type and schedule.
Rheumatology — Sjögren’s features2–4 weeks if Sjögren’s suspected; urgent if systemic organ involvementIf Sjögren’s features: send anti-Ro; anti-La; ANA; FBC; ESR; CRP; Ig; RF. Include in referral: sicca features (dry eyes; dry mouth); systemic features (joint pains; fatigue; Raynaud’s; parotid swelling); autoimmune history; OSDI score. Rheumatology will: complete workup (salivary gland USS; lip biopsy if needed); hydroxychloroquine for systemic symptoms; co-ordinate ophthalmology + oral medicine. Mrs. Chen: not applicable today — no dry mouth; no systemic features — documented as screened.Do NOT delay Sjögren’s referral if features are present — lymphoma risk requires formal diagnosis; monitoring; and appropriate specialist follow-up.
🎓 SCA Checkpoint — Step 6Tasks
Referral framing
"For most people with dry eye like yours, the changes we make today — the right drops; the lid hygiene routine; the screen habits — are enough to make a real difference. If after 6–8 weeks things are not significantly better, I will refer you to the eye clinic where there are additional treatments available. But I think we have a clear action plan to try first."
Deductions
  • Referring to ophthalmology before attempting first-line treatment — premature referral for a condition that has multiple effective GP-manageable interventions still to try
7
Step 7
Management — PF Drops · Lid Hygiene · Screen Habits · Medication Review · Contact Lenses · Omega-3
collapse
7A — Address Mrs. Chen’s expectation: drops that actually work
🤝
Mrs. Chen wants drops that actually work — validate the frustration; explain why the OTC drops have been inadequate; give a specific plan that addresses all her triggers
1
Validate — the OTC drops were not wrong; just insufficient

She has been using OTC lubricants from the chemist. These are not wrong — they are just not strong enough or frequent enough for moderate DED with contact lens use and high screen exposure.

"The drops you have been using are a reasonable start — but they are probably preserved, which is not ideal when you are using them frequently and wearing contact lenses. And dry eye is one of those conditions where the type of drop and the frequency both really matter."
2
Explain — why preservative-free matters; why drops alone are not enough

The preservative in her current drops (likely BAK) is being absorbed by her lenses and worsening the problem. And drops alone do not address the lid margin disease — the warm compress and lid hygiene are as important as the drops for evaporative DED.

"I am going to prescribe you a different type of drop — preservative-free, which is safe to use with your lenses. But I also want to add a lid hygiene routine — warm compresses and lid wipes — because the oil glands in your eyelids are part of the problem and drops alone won’t fix those."
3
Negotiate — a stepwise plan with realistic expectations

The plan is specific: PF drops ×4/day + warm compress BD + Blephasol + 20-20-20 rule + antihistamine review + humidifier. Realistic: 4–8 weeks to see meaningful improvement.

"This is going to be a combination approach — the drops; the lid routine; and some changes to your screen setup. Give it 6–8 weeks before we judge whether it is working. Most people with the same type of dry eye as you get significant improvement with this combination."
7B — Treatment goals
Treatment goals
OSDI reduction ≥7 points at 6–8 week reviewContact lens wear tolerable again Screen use comfortable — able to work without excessive symptomsParadoxical epiphora reduced as DED treated Antihistamine modified — hay fever controlled without contributing to DEDLid hygiene routine established and maintained PF drops used correctly; frequency documented6–8 week review booked; OSDI re-scored
Motivational language
"You have several very clear triggers — and most of them are modifiable. This is not a ‘nothing we can do’ situation; it is a ‘several things to fix at once’ situation."
"I want you to leave today with a clear plan — the right drops; the lid routine; and the screen changes. Most people with your type of dry eye see real improvement within 4–8 weeks when they do all three."
7C — Non-medication management
💻
20-20-20 Screen Rule
Every 20 min; look 20 feet away; 20 seconds; conscious blinking; screen below eye level
Why critical for Mrs. Chen

8–10 hours/day screen use. Blink rate falls from 15/min to 3–8/min with screen use — each blink renews the tear film. The 20-20-20 rule interrupts the screen-induced blink suppression cycle. Additionally: consciously blink fully and frequently during screen use; increase text size (reduces intense focus and blink inhibition); position screen below eye level (reduces exposed ocular surface area and evaporation rate).

Practical

Set phone reminders or use screen time apps (Time Out; Eye Care 20 20 20) to prompt 20-second breaks every 20 minutes. Blue light filters and anti-glare screen protectors: some evidence for comfort benefit. DSE assessment (employer obligation under Display Screen Equipment Regulations 1992): reduces glare; improves posture; optimises screen position.

20-20-20 rule: most immediately modifiable trigger; evidence for symptom reduction in screen-related DED
💥
Warm Compresses + Lid Massage
5–10 min warm compress BD; lid massage along lid margin; softens meibum
Why first-line for MGD

Warm compresses soften solidified meibum (meibomian secretion) — normal meibum melts at 28–32°C; abnormal MGD meibum melts at higher temperatures. Heating the lid to 40°C for 5–10 minutes restores the oily layer. Lid massage (gentle pressure along the lid margin after warming) expresses the softened meibum. EyeGiene Instant Warming Eye Mask; Bruder Moist Heat Eye Compress; warm damp flannel — all effective.

Practical technique

Heat flannel/compress to comfortable warmth (approximately 40°C). Apply to closed eyelids for 5–10 minutes BD. After warming: gently massage along the lid margin with a fingertip (upper lid: downward strokes; lower lid: upward strokes). Then clean lids with Blephasol or Ocusoft lid wipes. This sequence (heat; massage; clean) takes approximately 10–15 minutes BD. Build as a habit alongside morning and evening routine.

Warm compress + lid massage: RCT evidence for symptom improvement in MGD; as important as drops for evaporative DED
🌤
Environmental Modifications
Desk humidifier; reduce AC airflow; wraparound glasses outdoors; avoid smoke
Why

Air conditioning reduces ambient humidity significantly (40–60% RH in offices vs 30–50% with AC — AC can reduce to 20–30%). Low humidity directly accelerates tear evaporation. Desk humidifier (1–2L capacity; USB-powered; ultrasonic): maintains local humidity at workstation. Redirect AC vents away from face and workstation. Outdoor: wind accelerates evaporation; wraparound glasses reduce airflow across the ocular surface.

Practical

Small ultrasonic USB humidifier at workstation (available online; approximately £15–30). Adjust AC vents. Avoid fans directed at face. Wraparound glasses/sunglasses outdoors. Do not smoke; avoid smoky environments (direct toxin to tear film and meibomian glands). Sleep: ensure bedroom is not too dry; consider overnight eye ointment if waking with dry eyes (VitA-POS or Lacri-Lube ointment — blurs vision; apply just before sleep).

Humidifier: evidence for DED symptom reduction in low-humidity environments; modest but real benefit
💊
Antihistamine Modification
Switch to intranasal corticosteroid (fluticasone); or loratadine if COCP not used
Mechanism of harm

Antihistamines have anticholinergic effects — they reduce lacrimal secretion and goblet cell mucin production. All antihistamines worsen DED to some degree; first-generation (chlorphenamine) more than second-generation (cetirizine; loratadine). Intranasal corticosteroids (fluticasone nasal spray; mometasone nasal spray) are first-line for allergic rhinitis and have NO anticholinergic effect on the eyes — they are the preferred option for patients with DED and allergic rhinitis.

For Mrs. Chen

Options: (1) Switch cetirizine to fluticasone nasal spray (Flixonase; Avamys) 2 sprays each nostril OD — first-line for allergic rhinitis; no anticholinergic ocular effect. (2) Topical antihistamine eye drops (olopatadine; azelastine) instead of systemic for ocular symptoms. (3) If oral antihistamine preferred: loratadine (marginally less anticholinergic than cetirizine; small difference). Allergen immunotherapy: if hay fever is severe; specialist referral.

Intranasal corticosteroid: equivalent hay fever control; no anticholinergic DED contribution; first-line switch
🐝
Omega-3 Fatty Acids
EPA/DHA 500–2000mg/day; fish oil or flaxseed; adjunctive anti-inflammatory
Evidence

Omega-3 fatty acids (EPA; DHA) have anti-inflammatory effects on the ocular surface and meibomian glands — reduce production of inflammatory prostaglandins that contribute to MGD and evaporative DED. Evidence: multiple RCTs showing modest but consistent benefit on OSDI score and TBUT; DREAM trial (NEJM 2018) showed no benefit vs control (olive oil — which also has anti-inflammatory properties); effect size modest. NICE CKS recommends consideration in DED alongside other measures. Risk: very low; well-tolerated.

Practical

Fish oil capsules (EPA + DHA; total 1–2g/day); or flaxseed oil (ALA; converted to EPA/DHA with less efficiency). Take with food (improves absorption; reduces GI side effects). Not on blood thinners (modest antiplatelet effect — relevant if on warfarin or DOAC — discuss with prescriber). Dietary: oily fish (salmon; mackerel; sardines; tuna) 2×/week.

Omega-3: modest anti-inflammatory benefit; safe; low cost; adjunctive to lid hygiene and drops
👓
Contact Lens Advice
Always PF drops; not in lenses unless PF; timing advice; spectacle alternatives
Critical rules

1. ALL eye drops used by contact lens wearers must be preservative-free (BAK absorbed by lenses). 2. PF drops can be instilled while wearing lenses — safe in lenses. 3. Preserved drops: apply 15–30 minutes before lens insertion or after lens removal — give time for preservative to drain. 4. Consider spectacle alternatives on symptomatic days — reduces evaporation vs contact lens surface. 5. Optometrist review: daily disposable silicone hydrogel lenses have better oxygen transmissibility; consider if worsening. 6. Lens wear time: reduce if symptomatic; take lenses out earlier in the evening.

For Mrs. Chen

PF sodium hyaluronate drops: safe to use with lenses in. Reduce daily lens wear hours if symptomatic. Use spectacles for screen work on bad DED days. Optometrist review: assess whether daily disposable is the most appropriate lens type; discuss lubricating contact lens solutions. Never wear contact lenses if eye is red; painful; or discharging — seek same-day assessment.

PF drops with contact lenses: prevents BAK toxicity; maintains ocular surface health during lens wear
7D — Prescribing guide
Mrs. Chen (moderate DED; contact lens wearer; >4×/day use): preservative-free sodium hyaluronate (Hylo-Forte or Clinitas) ×4/day in or around lenses; carbomer 0.2% gel (Viscotears) at night if needed. Lid hygiene: warm compress BD + Blephasol lid wipes. Antihistamine: switch to fluticasone nasal spray. Omega-3 supplementation. Review 6–8 weeks.
Step 1: Lubricant drops — choose type and preserve status by frequency
  • Preserved (BAK): carmellose 0.5%; hypromellose 0.3%; Viscotears unit doses — use if <4×/day; cheaper; NOT for contact lens wearers
  • Preservative-free: sodium hyaluronate (Hylo-Forte; Hylo-Comod; Clinitas; Artelac) — ×4/day; contact lens wearers; >4×/day use; sensitive eyes; post-surgical
  • Carbomer gel (Viscotears; Gel-Tears; Clinitas Gel) — longer-lasting; better for night use; blurs vision temporarily; once or twice daily
  • Ointment (VitA-POS; Lacri-Lube; Hylo-Night) — overnight; thickest; best for exposure keratopathy or post-LASIK
Key rule: preservative-free if >4×/day or contact lens wearer. Preserved = BAK toxicity at high frequency.
Step 2: Lid hygiene — essential for evaporative / MGD type
  • Warm compress: 5–10 min at 40°C; EyeGiene Instant Warming Eye Mask; Bruder; warm damp flannel
  • Lid massage: after warming; gentle pressure along lid margin; upper and lower lids; expresses meibum
  • Lid wipes: Blephasol (recommended); Ocusoft; Lid-Care; Blephaclean; dilute baby shampoo; once or twice daily
  • Sequence: warm → massage → clean; BD minimum
Lid hygiene is as important as drops for evaporative DED — drops do not address the root cause (MGD).
Step 3: Antihistamine switch + omega-3
  • Switch cetirizine to: fluticasone nasal spray (Flixonase) — first-line for allergic rhinitis; no anticholinergic ocular effect
  • Or topical antihistamine eye drops (olopatadine 0.1%; azelastine 0.05%) for ocular symptoms specifically
  • Omega-3: fish oil 1–2g/day (EPA+DHA); with food; modest anti-inflammatory benefit
  • Humidifier at workstation; 20-20-20 rule; wraparound glasses outdoors
Antihistamine switch: removes a modifiable pharmacological trigger; may improve DED significantly.
Ikervis (ciclosporin 0.1%) — specialist / severe keratitis only
  • NICE TA369: licensed for severe keratitis in adult DED; failed adequate PF lubricant drops
  • One drop per affected eye once daily at bedtime
  • Side effects: stinging/burning on instillation (40%); photophobia; initial worsening
  • NOT for GP initiation — ophthalmology must confirm keratitis on slit lamp first
  • Once initiated: GP can continue prescription in shared care
What NOT to do
  • Preserved drops in a contact lens wearer — BAK toxicity; accumulates in lens material
  • Ikervis without ophthalmology assessment — specialist initiation only
  • Advise stopping contact lenses permanently before specialist review — premature; most patients can continue with right management
  • Ignoring the antihistamine as a contributing cause — modifiable pharmacological trigger
7E — Medication selector

Select DED type and severity — treatment guidance

DED treatment guidance
Moderate DED + contact lens wearer (Mrs. Chen): PF sodium hyaluronate drops (Hylo-Forte; Clinitas; Artelac) ×4/day — safe to use in contact lenses. Warm compress 5–10 min BD + Blephasol lid wipes BD. 20-20-20 screen rule + humidifier at workstation. Switch cetirizine to fluticasone nasal spray (Flixonase) — no anticholinergic ocular effect. Omega-3 fish oil 1–2g/day with food. Review OSDI at 6–8 weeks. Mild DED: preserved carmellose 0.5% or hypromellose 0.3% PRN if <4×/day (not contact lens wearers). Night symptoms: carbomer gel (Viscotears; Clinitas Gel) at bedtime; or VitA-POS ointment. Sjögren’s: PF drops ×6–8/day; preserve-free gels; anti-Ro; anti-La; ANA; rheumatology referral; ophthalmology. Keratitis confirmed: Ikervis (ciclosporin 0.1%) OD at night — ophthalmology initiation only; GP can continue in shared care. BAK-preserved anti-glaucoma drops: switch to PF formulation (latanoprost PF — Monopost; travoprost PF); discuss with ophthalmologist.
7F — Drug reference cards
Preservative-Free Sodium Hyaluronate
Hylo-Forte 0.2% · Hylo-Comod 0.1% · Clinitas 0.4% · Artelac Rebalance · Thealoz Duo · Unit-dose PF or COMOD multidose PF pump system
✓ Moderate DED; contact lens wearers; >4×/day use — safe in lenses; no BAK toxicity
Moderate DED — Mrs. Chen’s prescription; preservative-free essential×4/day minimum; more as needed; safe to use with lenses in
✓ Why sodium hyaluronate for Mrs. Chen
Sodium hyaluronate (HA) is a naturally occurring polymer found in the vitreous humour and synovial fluid. In DED: high molecular weight HA acts as a viscosity enhancer — coats and lubricates the corneal surface; retains moisture (hydroscopic); promotes corneal epithelial healing; prolongs contact time compared to simple saline-based drops. Preservative-free formulations use preservative-free COMOD multidose pump or unit-dose vials — no BAK; safe for contact lens wearers. Key difference from standard carmellose drops: longer contact time; better lubrication; more effective at higher concentrations (Hylo-Forte 0.2% > Hylo-Comod 0.1% for moderate-severe DED). Safe to apply while wearing contact lenses. Apply ×4/day minimum; can be used more frequently as needed.
✗ Key risk: preserved vs preservative-free confusion
Never prescribe PRESERVED drops for a contact lens wearer. BAK (benzalkonium chloride) in preserved drops is absorbed by soft contact lens material; concentrates over the wearing period; then releases onto the corneal surface — directly toxic to corneal epithelial cells; worsens DED. If prescribing eye drops for contact lens wearers: always prescribe preservative-free. If a patient uses preserved drops in lenses: wait 15–30 minutes after applying drops before inserting lenses; or apply after lens removal.
⚠ Practical points
Unit-dose vials (single-use): convenient; unambiguously preservative-free; more expensive per dose; waste if not all used. COMOD multidose pump (Hylo-Forte; Hylo-Comod): 300 drops per bottle; preservative-free; cost-effective; confirm pump mechanism is airtight (prevents contamination). Unit-dose vials can be used for up to 12 hours after opening if stored correctly. Refrigeration: not required. Instillation technique: instil drop in lower conjunctival sac; blink gently; avoid touching tip to eye.
🔬 Monitor
OSDI at 6–8 week review. Are drops being used at correct frequency (≥4×/day)? Check technique (lower conjunctival sac; not touching eye; COMOD pump functioning). Are drops in addition to lid hygiene? Drops without lid hygiene in evaporative DED = incomplete treatment. Escalate to ophthalmology if OSDI not improving at 8 weeks.
💬 For Mrs. Chen

"These drops are preservative-free — which means they are safe to use with your contact lenses in. Use them at least 4 times a day — ideally when you first wake up; mid-morning; mid-afternoon; and before bed. You can use them more often if you need to. These are different from the drops you have been buying over the counter — the preservative in those drops gets absorbed by your contact lenses and makes the dryness worse."

PF sodium hyaluronate: essential for contact lens wearers (>4×/day use); safe in lenses; no BAK toxicity. SCA: prescribing preserved drops for a contact lens wearer = Tasks error. Hylo-Forte 0.2% is stronger than Hylo-Comod 0.1% — for moderate DED prefer 0.2% concentration. Document: “PF drops prescribed; safe for use with contact lenses; 4×/day minimum.”

Preserved Lubricant Drops (Mild DED Only)
Carmellose 0.5% (Celluvisc) · Hypromellose 0.3% · Systane · Optive · Soothe · Use <4×/day; NOT for contact lens wearers
✓ Mild DED only — <4×/day; NOT contact lens wearers; BAK toxicity at high frequency
Mild DED only — <4×/day; first-line if OSDI 13–22PRN or ×2–3/day; preserved; lower cost; NOT in contact lenses
✓ When preserved drops are appropriate
Preserved lubricant drops are appropriate for mild DED (OSDI 13–22) where use is infrequent (<4 times/day). They are lower cost; widely available OTC; and effective for occasional use. Main preservative: benzalkonium chloride (BAK 0.01–0.02%). At low frequency of use (<4×/day): BAK clears from the ocular surface between doses and does not accumulate to toxic levels. Carmellose (cellulose) 0.5%: good viscosity; retentive; OTC and prescription. Hypromellose 0.3%: thinner; well tolerated; OTC. Single-use preservative-free alternatives available for all.
✗ Absolute rule: NOT in contact lenses; NOT >4×/day
NEVER prescribe preserved drops for contact lens wearers — BAK accumulates in lens material and is released as a concentrated dose onto the corneal surface. NEVER use preserved drops more than 4 times daily — BAK accumulates on the corneal epithelium at higher frequency; causes direct toxicity; worsens DED. If patient requires drops more than 4 times daily: switch to preservative-free formulation regardless of cost.
⚠ Counselling point
Inform patients of the frequency limit: “These drops are fine for occasional use — up to 3–4 times a day. If you find you need them more often than that; please let me know and we will switch to a different type.” This prevents inadvertent harmful overuse.
🔬 Monitor
OSDI at 6–8 weeks. If frequency increasing beyond 4×/day: switch to PF formulation. If contact lens wear started: prescribe PF formulation immediately. If symptoms not improving: add lid hygiene; switch to PF; review medications.
💬 Counselling

"These drops are for mild symptoms — use them when your eyes feel uncomfortable. Up to 3–4 times a day is fine. If you find yourself reaching for them more often than that; come back and I can give you a different type that is safe to use more frequently."

Preserved drops: mild DED; <4×/day; NEVER contact lens wearers; NEVER >4×/day. SCA: the commonest prescribing error is preserved drops for a contact lens wearer. Mrs. Chen requires PF drops — not preserved.

Carbomer Gel / Lubricant Gel (Night)
Viscotears 0.2% gel · Clinitas Gel · Gel-Tears · VitA-POS ointment · Lacri-Lube · Hylo-Night ointment · Blurs vision temporarily — at night
✓ Night symptoms; exposure keratopathy; post-LASIK — longer-lasting; blur; apply at bedtime
Night-time or severe DED supplement — alongside daytime PF dropsCarbomer gel OD–BD; ointment once at bedtime; blurs vision (drive before applying)
✓ Role: longer-lasting night protection
Carbomer gels (Viscotears; Clinitas Gel): cross-linked polyacrylic acid; viscous gel that forms a prolonged film on the ocular surface; longer contact time than drops. Ideal for: night-time DED (waking with dry eyes); between daytime drop applications when more sustained relief is needed; supplement to daytime PF drops. Causes transient blurring (gel consistency) — apply at night; or if applying during day; instruct patient to avoid driving immediately after. VitA-POS / Lacri-Lube ointment: paraffin-based; thickest; most prolonged effect; significant blurring — bedtime only; ideal for exposure keratopathy (TED; lagophthalmos) and post-LASIK overnight protection. Hylo-Night: ointment-consistency; paraffin + lanolin; preservative-free.
✗ Driving after gel/ointment application
Carbomer gel and ointments blur vision temporarily after instillation. Never drive or operate machinery immediately after applying. Apply at night (bedtime) — vision clears on waking. Daytime use: sit for 5–10 minutes after instillation until vision clears; do not drive. Document and counsel: “this will blur your vision for a few minutes after applying — apply at bedtime.”
⚠ Contact lens compatibility
VitA-POS and Lacri-Lube (paraffin-based): NOT for use with contact lenses (paraffin destroys lens material). Remove lenses before applying overnight ointment — reinsert in morning. Carbomer gels (Viscotears PF unit-dose): some PF formulations can be used with lenses — check the specific product. Preserved carbomer gels: not for contact lens wearers.
🔬 Monitor
OSDI at 6–8 weeks. Night-time symptom resolution (waking with eyes comfortable). If exposure keratopathy (TED; post-LASIK): optometrist/ophthalmology review to assess corneal surface. Ensure patient applying technique is correct (lower fornix; blink; close eye gently).
💬 Counselling

"This gel is thicker than the drops — it stays on your eye surface for longer, which is why it is good at night. When you first put it in, it will blur your vision briefly — which is why I suggest using it just before you go to sleep. Your vision is fine in the morning."

Carbomer gel: night-time DED; longer contact time; blurs vision (apply at bedtime; not before driving). NOT paraffin ointment in contact lenses. SCA: counselling point about temporary blurring is a safety communication — document “patient advised not to drive after gel instillation.”

Lid Hygiene (Warm Compress + Blephasol)
EyeGiene warming mask · Bruder Moist Heat Compress · Warm flannel · Blephasol cleansing solution · Ocusoft · Lid-Care · Blephaclean · Dilute baby shampoo
✓ Evaporative DED / MGD — warm compress + lid massage + lid wipes BD; as important as drops
First-line MGD/evaporative DED — as important as lubricant drops; targets the root causeWarm compress 5–10 min; lid massage; Blephasol wipe; BD sequence; morning and evening
✓ Why lid hygiene is as important as drops in evaporative DED
Drops replace the tears; lid hygiene treats the cause. In evaporative DED (MGD-driven), the meibomian glands are obstructed — warm compresses (at 40°C for 5–10 minutes) melt the solidified meibum; lid massage then expresses it; lid wipes remove lid margin debris and biofilm that perpetuates the inflammation. Without lid hygiene, drops alone provide temporary relief but do not address the root cause. The Sequence: (1) Warm compress 5–10 min; (2) Lid massage (upper lids: sweep downward; lower lids: sweep upward; 1–2 minutes); (3) Lid wipe (Blephasol soaked lint-free pad; swipe along lid margin). Morning and evening ideally — minimum once daily at bedtime if BD not achievable.
✗ Common mistakes
Not warming for long enough (minimum 5 minutes to reach therapeutic temperature of 40°C). Not massaging after warming (warming without massage does not express the meibum). Using baby wipes or general wipes (not formulated for lid margin; may irritate). Sharing lid wipes (infection risk). Stopping after symptoms improve (lid hygiene must continue long-term as maintenance; MGD recurs without ongoing lid care).
⚠ Products and availability
Blephasol cleansing solution & pads: available OTC; no-rinse formula; well tolerated. Ocusoft original: OTC; good for blepharitis. EyeGiene Instant Warming Eye Mask (SPA Scientific): reusable; self-activating; convenient. Bruder Moist Heat Eye Compress: reusable; microwaveable; popular. All available online. Warm damp flannel: adequate; patient compliance may be lower. Lid massage technique: optometrist/nurse can demonstrate at review. Lid wipes and warming compresses are not available on NHS prescription — OTC purchase only.
🔬 Monitor
OSDI at 6–8 weeks. Is lid hygiene being performed BD? Is the technique correct (warm; massage; clean sequence)? Are the lid margins improving (less erythema; less capping on examination)? If not improving despite compliance: meibography (optometrist/ophthalmology); IPL (intense pulsed light) or LipiFlow (thermal pulsation) — specialist MGD treatments.
💬 For Mrs. Chen

"The oil glands along your eyelids are blocked — like a blocked pore in your skin. The warm compress softens the oil; then you massage it out; then you clean the lid edge. It takes about 10 minutes morning and evening. I know that sounds like a lot — but for most people with the type of dry eye you have, this routine makes as much difference as the drops, if not more. After a few weeks it becomes quick and automatic."

Lid hygiene: as important as drops for evaporative DED; targets root cause (MGD). Warm compress (5–10 min) → lid massage → Blephasol lid wipes; BD. SCA: not mentioning lid hygiene in evaporative DED = incomplete management; Tasks deduction. Products are OTC — cannot be prescribed on FP10; patient buys them. Demonstrate technique or refer for optometrist demonstration.

Omega-3 Fatty Acids (EPA/DHA)
Fish oil capsules · Flaxseed oil (ALA) · Mackerel; salmon; sardines; tuna (dietary) · Adjunctive anti-inflammatory · OTC supplement; not NHS Rx
✓ Adjunctive — modest anti-inflammatory benefit on meibomian glands; safe; OTC
Adjunctive — alongside lid hygiene and drops; not standalone treatmentEPA + DHA 1–2g/day with food; or dietary: oily fish 2×/week; 3-month trial
✓ Role in DED
Omega-3 fatty acids (EPA; DHA) reduce production of pro-inflammatory prostaglandins and cytokines at the ocular surface and meibomian glands — addressing the inflammatory component of MGD and evaporative DED. Multiple small RCTs show improvement in OSDI score; TBUT; and meibomian gland secretion quality. The DREAM trial (NEJM 2018; n=535) showed no significant difference vs control (refined olive oil); however olive oil also has anti-inflammatory properties, so the true treatment effect may be underestimated. NICE CKS recommends consideration alongside other measures. Risk profile: very low; safe for most patients.
✗ Cautions
Blood thinners: omega-3 has modest antiplatelet effect — discuss with prescriber before starting if on warfarin; DOAC; antiplatelet agents. Fish allergy: use flaxseed oil (plant-derived ALA) instead of fish oil. GI side effects: nausea; fishy aftertaste; diarrhoea — take with food; enteric-coated capsules reduce. Note: fish oil supplements are NOT prescribable on NHS for DED — patient purchases OTC.
⚠ Products and practical use
Fish oil capsules (OTC): choose EPA + DHA total 1–2g/day; many brands (Seven Seas; Healthspan; Holland and Barrett). Enteric-coated: reduces fishy aftertaste. Flaxseed oil: 1 tablespoon/day (approximately 2.5g ALA); vegans/vegetarians. Dietary sources: salmon 100g = approximately 1.8g EPA+DHA; mackerel = approximately 2.5g. Allow 3 months for full effect. Not prescribable on FP10 for DED indication — patient self-purchases.
🔬 Monitor
OSDI at 3 months: is it improving alongside other measures? If no improvement at 3 months with full supplement + lid hygiene + PF drops: the omega-3 has not made a difference for this patient; discontinue and focus on escalating other measures. Not a long-term prescription — review at each DED review.
💬 Counselling

"I would also suggest omega-3 fish oil — you can buy this over the counter at any pharmacy or supermarket. It has mild anti-inflammatory properties that can help the oil glands in your eyelids. It is not a dramatic treatment; but it is safe; cheap; and adds to the benefit of everything else we are doing. 1–2 capsules a day with food."

Omega-3: adjunctive; modest evidence; safe; OTC (not prescribable on FP10). Mention as part of the complete management plan for MGD/evaporative DED. Do not overstate the evidence — “modest benefit; safe; worth trying alongside the other measures.” SCA: suggesting omega-3 as part of a holistic plan demonstrates knowledge of NICE CKS management approach.

Ikervis (Ciclosporin A 0.1%)
Ikervis cationic emulsion 0.1% · NICE TA369 · Severe keratitis + DED · Failed PF lubricant drops · Ophthalmology initiation only · 1 drop OD at bedtime
✓ Severe keratitis in DED — ophthalmology initiation; GP can continue in shared care
Specialist only — failed PF drops; keratitis confirmed; ophthalmology initiates1 drop each affected eye OD at bedtime; continue PF drops alongside; minimum 12 months
✓ Indication and mechanism
Ikervis (ciclosporin A 0.1% cationic emulsion): topical T-cell inhibitor; blocks calcineurin → inhibits IL-2 and T-cell proliferation → reduces ocular surface inflammation. Inflammation is a central component of DED — Th1 and Th17 T-cells are elevated in the lacrimal glands and conjunctiva; inflammatory cytokines damage goblet cells and meibomian glands. NICE TA369 criteria: severe keratitis (confirmed by slit lamp staining — corneal staining grades 3–4/4 per Oxford scale or Van Bijsterveld score ≥4); adult patient; DED not adequately managed with PF artificial tears. One drop per affected eye OD at bedtime. Continue PF drops alongside — Ikervis treats inflammation; PF drops treat lubrication.
✗ Not for GP initiation
Ikervis must NOT be initiated in primary care without ophthalmology assessment. Reason: NICE TA369 requires confirmation of keratitis by slit lamp — this is an ophthalmological examination not available in GP. GP role: (1) optimise all first-line measures (PF drops; lid hygiene; medication review); (2) refer to ophthalmology if failing; (3) after ophthalmology initiates Ikervis: GP can continue prescribing in shared care; monitor for side effects; support adherence.
⚠ Side effects — counsel explicitly
Transient stinging/burning on instillation (approximately 40% of patients — most common reason for discontinuation). Photophobia. Initial worsening of symptoms in weeks 1–2 (as inflammation is treated; the surface may initially feel more sensitive). Reassure: stinging usually reduces after 1–2 weeks; continue through initial side effects. Night application reduces daytime photophobia. Not immunosuppressive systemically at eye drop dose. If stinging intolerable: apply immediately before sleep to minimise awareness of burning.
🔬 Monitor (GP shared care)
OSDI at 3 months: keratitis improvement on slit lamp (ophthalmology); TBUT improvement. Side effects: stinging; photophobia (usually improve over 2–4 weeks; if persistent: ophthalmology review). Minimum 12 months of treatment to assess full effect; DED is chronic and may require indefinite treatment. Annual ophthalmology review. Concurrent PF drops must continue throughout.
💬 Counselling

"This drop works on the inflammation underneath the dryness. When you first start it, it may sting or burn for a minute or so after putting it in — that is completely normal and usually settles after a couple of weeks. Put it in just before you go to sleep, so any stinging happens while you are going off to sleep. Keep using your other drops during the day alongside this one."

Ikervis: NICE TA369; severe keratitis + DED; failed PF drops; ophthalmology initiation only; GP can continue shared care. Stinging/burning common — counsel to persevere. 1 drop OD at bedtime; continue PF drops alongside. SCA: knowing that Ikervis exists; its indication; and that it requires specialist initiation demonstrates clinical depth about DED management beyond step 1–2 treatment.

7G — Psychosocial impact of dry eye disease
🧑️
Dry eye disease directly affects Mrs. Chen’s ability to do her job; wear her contact lenses; and function comfortably in her daily environment
OSDI-derived quality of life impairment in moderate DED is comparable to moderate chronic pain conditions. Chronic eye discomfort causes fatigue; difficulty concentrating; reduced work productivity; and frustration with a condition that others may trivialise. Mrs. Chen’s professional function and personal comfort depend on effective DED management.
💼
Occupational Function

8–10 hours/day screen use. DED is an occupational disability. DSE workplace assessment (employer legal obligation). Documented OSDI score supports reasonable adjustment requests. Screen position; anti-glare protectors; humidifier; breaks.

"As an accountant you need to be at a screen for most of the day. I want to help you make that possible without your eyes suffering."
👓
Contact Lens Independence

Daily lens intolerance is frustrating and affects personal choice. The goal of management is to restore contact lens comfort — PF drops + lid hygiene + reduced BAK exposure will in most cases allow lenses to be tolerated again. Reassure: stopping lenses is not inevitably necessary.

"Getting the dry eye under control should allow you to wear your lenses comfortably again — that is one of our treatment goals."
🚘
Driving Comfort

DED with photophobia or blurred vision in bright light (common) affects driving comfort; especially oncoming headlights at night. PF drops before driving improves comfort. Advise: apply drops before driving in low humidity; use wraparound glasses; avoid overnight ointment before driving.

"If you find driving uncomfortable — especially at night or in bright conditions — try applying the drops just before you drive."
💕
Menopausal Context

Post-menopausal oestrogen and androgen deficiency worsens MGD. If other menopausal symptoms are present: transdermal HRT may benefit both. This is an opportunity for holistic menopausal health review alongside the DED management.

"Are there any other menopausal symptoms you are experiencing? The menopause does contribute to dry eye — there may be a treatment that addresses both."
📈
Prognosis

DED is chronic. Management; not cure. However: Mrs. Chen has multiple identifiable and modifiable triggers — most patients with evaporative DED driven by modifiable factors see significant improvement with the combined approach. Realistic timeframe: 4–8 weeks for meaningful OSDI improvement.

"Dry eye is ongoing — but for most people with your type, the combination approach makes a real and lasting difference. Most of my patients see significant improvement within 4–8 weeks."
💓
Anxiety about Vision

Many patients with DED fear permanent vision loss. The reassurance is specific: DED rarely causes permanent vision damage when treated; blurred vision in DED is from tear film instability; not retinal or nerve disease; treating DED restores visual clarity. If corneal staining present: address more urgently; ophthalmology; but still reassure about prognosis.

"I want to reassure you — dry eye is uncomfortable but it is very rarely threatening to your vision in the long term, especially when we manage it properly."
7H — Follow-up
T
Today — PF drops; lid hygiene advice; antihistamine switch; OSDI baseline

Hylo-Forte 0.2% (or Clinitas; Artelac) PF sodium hyaluronate ×4/day; safe in lenses. Warm compress BD + Blephasol lid wipes (OTC — patient purchases). Switch cetirizine to fluticasone nasal spray OD (Flixonase). Omega-3 fish oil supplement advice (OTC). 20-20-20 screen rule. Humidifier advice. OSDI baseline score documented. Contact lens timing advice (PF drops: safe in lenses; preserved: 15–30 min gap). 6–8 week review booked.

6–8 week review booked before Mrs. Chen leaves
2
6–8 Weeks — OSDI re-score; lid hygiene compliance; contact lens comfort

OSDI re-score: clinically meaningful response = ≥7-point reduction. Lid hygiene: is the warm compress + Blephasol routine established? Frequency: ×4/day drops? Antihistamine: switched to fluticasone? Hay fever controlled? Contact lens comfort improved? If improving: continue; plan long-term management. If not improving: intensify (drops more frequently; carbomer gel at night); optometrist review; consider ophthalmology if OSDI still >33.

OSDI re-score; contact lens comfort; lid hygiene compliance; antihistamine check
3
3 Months — Omega-3 assessment; medication review

Omega-3: OSDI improving? (3 months for full omega-3 effect). Review all medications for ongoing DED contribution. Sjögren’s: have any new systemic features emerged (dry mouth; joint pains)? If OSDI not improving at 3 months despite full step 1–2 compliance: ophthalmology referral. HRT discussion if other menopausal symptoms have emerged.

Omega-3 assessment; medication review; Sjögren’s update; HRT discussion
4
Ophthalmology (if referred) — Slit lamp; TBUT; meibography; Ikervis assessment

Ophthalmology will: slit lamp + fluorescein staining (keratitis grade); TBUT; Schirmer’s; meibography. Consider: Ikervis if keratitis grade ≥3/4; punctal plugs if aqueous-deficient; LipiFlow or IPL if severe MGD. GP shared care: continue Ikervis prescription; monthly phone check in first 3 months; annual ophthalmology review.

Ophthalmology assessment; Ikervis if keratitis; GP shared care role
5
Annually — OSDI; lid hygiene adherence; medication review; Sjögren’s check

Annual OSDI. Lid hygiene ongoing? Drug history update (new anticholinergic; new BAK drops). Sjögren’s: any new systemic features? Menopause: HRT review. Contact lens tolerance: optometrist review. Ophthalmology annual review if on Ikervis or has keratitis history.

Annual OSDI; medication; Sjögren’s; menopause; ophthalmology if Ikervis
7I — Monitoring — DAMP mnemonic

DAMP monitoring mnemonic for dry eye disease

Drops: PF; frequency; contact lens timing; technique. Antihistamine: switched to fluticasone? Other anticholinergic drugs started? BAK-preserved glaucoma drops? Meibomian lid hygiene: warm compress BD; Blephasol; compliance; technique. Progress: OSDI re-score at 6–8 weeks; ≥7-point reduction = response; Sjögren’s new features?

InterventionMonitorTimingAction
PF sodium hyaluronate dropsOSDI score; contact lens comfort; drop frequency6–8 weeksOSDI not improving: intensify; add gel at night; ophthalmology. Frequency <4×/day: educate and re-emphasise.
Lid hygiene (warm compress + Blephasol)OSDI symptoms; lid margin appearance; compliance6–8 weeksNot compliant: simplify to OD; build habit slowly. Lid margins not improving: ophthalmology; meibography; LipiFlow consideration.
Antihistamine switch (fluticasone)Hay fever control; DED symptom improvement6–8 weeksHay fever not controlled: add topical antihistamine eye drops (olopatadine). DED improved after switch: confirms antihistamine was contributing.
Ikervis (if ophthalmology initiated)Stinging/burning; OSDI; annual keratitis reviewMonthly (first 3 months); then annually (ophthalmology)Stinging persists >4 weeks: ophthalmology review. OSDI not improving at 3 months: reassess diagnosis; ophthalmology.
MilestoneAction
6–8 weeksOSDI re-score; drops frequency; lid hygiene compliance; antihistamine check; contact lens comfort; Sjögren’s screen update
3 monthsOmega-3 assessment; all step 1–2 optimised; ophthalmology referral if OSDI still >33
On IkervisMonthly phone review ×3 months then annual ophthalmology
AnnuallyOSDI; medication review; Sjögren’s; menopause; ophthalmology if keratitis history
7J — Safety-netting

⚠ Three critical safety-nets for Mrs. Chen

🔴 Emergency — vision-threatening features
"I want to tell you about some specific warning signs that would need urgent attention. If you develop sudden blurring of vision; severe eye pain; haloes around lights; or your eye becomes very red and painful — especially if you are wearing your contact lenses — go to A&E or the eye emergency clinic immediately. Do not wait for a GP appointment."
AACG and contact lens keratitis are vision-threatening. Mrs. Chen as a contact lens wearer is at higher risk of Acanthamoeba keratitis. This safety-net must be specific and documented.
💊 Contact lens safety — when NOT to wear lenses
"If your eye is red; painful; or has a discharge — take your contact lenses out and do not put them back in until the eye is fully recovered and you have been assessed. Never wear lenses in a red or sore eye — it can cause a serious infection that can damage your vision."
Contact lens keratitis is vision-threatening. Patients often continue wearing lenses despite symptoms, increasing infection risk. This specific rule must be stated.
🟠 Treatment — if drops are not helping at 6–8 weeks
"If after 6–8 weeks of using the drops 4 times a day AND doing the warm compress routine, your symptoms are not improving — come back and let me know. There are additional treatments available and I may refer you to the eye clinic at that stage."
Prevents both premature discontinuation (“they didn’t work after 2 weeks”) and indefinite tolerance of inadequate treatment. Sets a clear timeframe for review.
A&E immediatelySudden VA loss; severe pain; haloes; red eye with lenses in — do not wait
6–8 weeksOSDI re-score; drops frequency; lid hygiene compliance; antihistamine effect
3 monthsFull step 1–2 assessment; ophthalmology referral if OSDI still >33
🎓 SCA Checkpoint — Step 7 (Final)TasksRelating to OthersGlobal Skills
Closing the consultation
"Let me pull together the plan. You have dry eye disease — the most common type, driven by the oil glands in your eyelids. The watering and the dryness are two sides of the same problem."
"I am prescribing you preservative-free drops — these are safe to use with your contact lenses in, which is important. Use them at least 4 times a day. I am also suggesting a warm compress and lid cleaning routine twice a day — that targets the oil gland blockage that drops cannot fix on their own."
"I also want to switch your hay fever tablet to a nasal spray instead — the tablet has a mild drying effect on your eyes. The nasal spray works just as well for the hay fever without that problem."
"One important warning: if your eye becomes very red or painful — especially with your contact lenses in — take the lenses out and go to A&E or the eye clinic that day. Before you go — is there anything we haven’t covered?"
Deductions
  • Prescribing preserved drops for a contact lens wearer — BAK toxicity; worsens DED
  • Not explaining paradoxical epiphora — Mrs. Chen remains confused about her diagnosis
  • Not identifying antihistamine as a contributing factor — modifiable trigger not addressed
  • Not mentioning lid hygiene — drops alone do not address the root cause of evaporative DED
  • Not safety-netting contact lens keratitis — contact lens wearers have specific emergency signs
Tasks summary
  • PF drops prescribed correctly (contact lens wearer; >4×/day)
  • Paradoxical epiphora explained
  • Antihistamine identified and switched
  • Lid hygiene regimen: warm compress + Blephasol BD
  • Contact lens safety-net; AACG emergency features
  • OSDI baseline; 6–8 week review; Sjögren’s screened
Relating to Others
  • Occupational frustration (screen; accountant) acknowledged
  • Contact lens frustration acknowledged; reassurance given
  • Paradoxical epiphora clearly explained
  • Menopausal context raised sensitively
🔴 Red
Preserved drops for contact lens wearer; epiphora not explained; antihistamine not identified; lid hygiene not mentioned; contact lens emergency safety-net absent; Sjögren’s not screened; OSDI not administered
🟠 Amber
PF drops prescribed; antihistamine identified; epiphora explained; screen advice; no lid hygiene; contact lens safety-net absent; OSDI not administered; Sjögren’s not screened; omega-3 not mentioned
🟩 Green
Occupational impact acknowledged; paradoxical epiphora explained; PF drops ×4/day; warm compress + Blephasol BD; antihistamine → fluticasone; 20-20-20 rule; humidifier; omega-3; contact lens timing advice; OSDI baseline; Sjögren’s screened; contact lens safety-net; AACG emergency; 6–8 week review; menopausal context; closing question
Dry Eye Disorder — SCA Consultation Scorecard
NICE CKS · PF drops (contact lens wearer) · Paradoxical epiphora explained · Lid hygiene · Antihistamine switch · 20-20-20 · Sjögren’s screen · Contact lens safety-net
0/ 33 pts
🌐
Global Skills
Structure; explanation; safety communication
0/7
Tasks
Clinical reasoning; DED type; prescribing; referral
0/15
🤝
Relating to Others
Empathy; explanation; shared plan
0/11
RAG Self-Assessment
🔴 Red
Preserved drops for contact lens wearer; epiphora not explained; antihistamine not identified; lid hygiene absent; Sjögren’s not screened; contact lens safety-net absent; OSDI not administered; 20-20-20 not discussed
🟠 Amber
PF drops prescribed; antihistamine identified; epiphora explained; 20-20-20 rule; no lid hygiene discussed; OSDI not administered; Sjögren’s not screened; contact lens safety-net absent; omega-3 not mentioned
🟩 Green
All: occupational acknowledged; epiphora explained; PF drops ×4/day; warm compress + Blephasol BD; antihistamine → fluticasone; 20-20-20; humidifier; omega-3; contact lens timing; OSDI; Sjögren’s; emergency safety-net; menopausal context; 6–8 week review; closing question
011172533
Fail
Borderline
Pass
Strong pass
📋
Complete the checklist to see your score and feedback
"I have had really dry, gritty, uncomfortable eyes for about 6 months and they just keep getting worse. And the strange thing is they are also watering all the time — so they feel dry but they stream as well. I went to my optician 3 months ago and they said to use artificial tears but I’ve tried a few different ones and none of them seem to really help. Can you give me something that will actually work?"
Who you are

Patricia Chen, 54, accountant; post-menopausal (last period 2 years ago; no HRT). 8–10 hours/day on screens for work. Daily disposable contact lens wearer — increasingly uncomfortable with lenses in. Cetirizine 10mg OD for seasonal hay fever (spring and summer mainly; currently spring). Air-conditioned office. OSDI at this consultation: 28 (moderate DED). No dry mouth; no joint pains; no fatigue; no systemic features.

Hidden agenda — disclose if asked

Fear of vision damage (disclose if asked about concerns): “I’m worried that if I leave this untreated it might damage my eyes permanently. The optician wasn’t very clear about whether it could cause lasting harm.” Respond well to: “Dry eye is very unlikely to threaten your vision when treated properly — you are not at risk of permanent damage from this.”

Contact lens question (raise if GP mentions drops): “Can I use the drops with my lenses in? Or do I have to take them out every time?” This distinguishes preserved from preservative-free prescribing.

Responses to key conversations
  • On paradoxical epiphora explanation: “Oh — so the streaming is because the eye is dry? I had no idea. I thought the two things were unrelated.”
  • On antihistamine switch: “I hadn’t thought of that. Does the nasal spray work as well as the tablet? I find the tablet easier.” — Respond well if GP explains equivalence and no ocular side effect.
  • On lid hygiene: Initially: “That sounds like quite a lot of effort — twice a day?” Respond well if GP explains it becomes quick and why it is important: “OK — if it’s really going to make a difference to the oil glands I can see why just drops aren’t enough.”
  • Challenge: “I’ve been using the drops from the optician for 3 months and they really haven’t helped. Why are these drops going to be any different?”
Clinical details
  • Bilateral; gritty; burning; stinging; paradoxical epiphora; worse in wind and air conditioning; worse end of working day
  • No acute pain; no haloes; no sudden VA change; no discharge (allergic conjunctivitis or keratitis features absent)
  • Lid margin examination: mild erythema bilateral; some capping of meibomian gland orifices; turbid meibum on expression — confirms evaporative MGD type
  • VA: normal; mildly fluctuating but improves with blinking — consistent with tear film instability
"I’ve been using the drops for 3 months and they really haven’t helped. Why are the ones you are prescribing going to be any different from what I’ve been buying?"

Resolution: “Two important differences. First: the drops you have been using are almost certainly preserved — the preservative in them is absorbed by your contact lenses and makes the dryness worse. The drops I am prescribing have no preservative — that’s a genuine difference. Second: I am also adding a warm compress and lid cleaning routine — because your oil glands are blocked, and drops alone can’t unblock them. That routine addresses the cause; the drops address the symptoms.” Mrs. Chen leaves: “I actually feel like I understand what’s causing it now, and the plan makes sense. Thank you for taking the time to explain it.”

🏥
Clinic Quick Reference
Dry Eye Disorder — Clinical Decision Framework
NICE CKS · DEWS II · PF drops if >4×/day or contact lens wearer · MGD: warm compress + Blephasol · Antihistamine switch · Sjögren’s screen · OSDI at every visit
expand
💊 1 — DED Triage and Action
Dry eye → Emergency excluded (AACG; keratitis; VA loss) → Type (evaporative vs aqueous-deficient) → OSDI severity → Step treatment
🔴 Emergency/Urgent
  • AACG: red eye; haloes; severe pain → 999; IV acetazolamide
  • Keratitis (contact lens wearer): severe pain; purulent → same-day ophthalmology
  • Sjögren’s features: anti-Ro; anti-La; rheumatology
999 / Same-day ophthalmology / Rheumatology
🟠 Referral Triggers
  • OSDI >33; failing step 1–2 at 6–8 weeks
  • Keratitis on slit lamp → Ikervis consideration
  • Post-LASIK; TED; aqueous-deficient
Routine ophthalmology
🟩 GP-managed
  • Mild (OSDI 13–22): preserved drops PRN; lifestyle; lid hygiene
  • Moderate (OSDI 23–32; Mrs. Chen): PF sodium hyaluronate ×4/day; warm compress + Blephasol BD; antihistamine switch; omega-3
NICE CKS stepwise; OSDI review 6–8 weeks
📊 2 — Key Clinical Numbers
PF if >4×/day
Preservative-free mandatory if using drops >4 times daily. BAK accumulates at higher frequency — directly toxic to corneal epithelium; worsens DED.
PF in contact lenses
Contact lens wearers: always PF drops. BAK absorbed by lens material; concentrates; releases onto cornea. PF drops: safe to use while wearing lenses.
MGD ~85% of DED
Most common type. Warm compress (5–10 min; 40°C) + lid massage + Blephasol lid wipes BD — targets root cause. Drops alone insufficient for evaporative DED.
Sjögren’s: anti-Ro; anti-La
Dry eyes + dry mouth + systemic features. Anti-Ro (SS-A); anti-La (SS-B); ANA; RF. Lymphoma risk 40–60× — long-term monitoring required.
OSDI 0–100
0–12 normal; 13–22 mild; 23–32 moderate; >33 severe. ≥7-point reduction = clinically meaningful response. Use at every DED consultation.
20-20-20 rule
Every 20 min; look 20 feet; 20 seconds. Restores blink rate. Most immediately modifiable trigger for screen-related DED.
Paradoxical epiphora
Watery eyes = reflex tearing from DED — not over-production. Reflex tears lack oily layer; wash away rapidly; leave surface dry. Explain always.
TBUT <10s = DED
Tear break-up time: normal >10s; <10s = DED; <5s = severe evaporative. Optometrist/ophthalmology — not available in primary care without slit lamp.
Schirmer’s <5mm = ADDE
Aqueous-deficient dry eye. <5mm/5min. Sjögren’s; post-radiation; age-related lacrimal insufficiency. Ophthalmology/optometrist performs.
Ikervis: specialist only
Ciclosporin 0.1% (NICE TA369). Severe keratitis + DED; failed PF drops; ophthalmology confirms keratitis. 1 drop OD at night. Stinging common — persevere.
Antihistamines worsen DED
Anticholinergic effect → reduced lacrimal secretion. Switch to fluticasone nasal spray (no anticholinergic ocular effect). First-line hay fever; equivalent efficacy.
BAK in glaucoma drops
Benzalkonium chloride in glaucoma drops worsens DED. Switch to PF formulation (Monopost; travoprost PF; bimatoprost PF) where available.
⚠ 3 — DAMP Monitoring
DAMPParameterTimingAction
DropsPF? Frequency (≥4×/day)? Correct technique? Contact lens timing?Every 6–8 weeksPreserved in lens wearer: switch to PF immediately. <4×/day: re-educate. OSDI not improving: intensify; add gel; ophthalmology.
AntihistamineSwitched to fluticasone? Any new anticholinergic or BAK drug started?Every reviewNot switched: re-discuss. New BAK glaucoma drops: switch to PF formulation.
Meibomian lid hygieneWarm compress BD? Blephasol? Technique (warm → massage → clean)?Every 6–8 weeksNot compliant: simplify; demonstrate technique; build to BD. Failing despite compliance: ophthalmology; meibography; LipiFlow consideration.
Progress (OSDI)OSDI re-score; ≥7-point reduction target; Sjögren’s new features?6–8 weeks; then every 3–6 monthsOSDI not reducing: ophthalmology if >33 at 8 weeks. New dry mouth or systemic features: Sjögren’s screen.
🎓
SCA Exam Quick Reference
DED SCA — PF drops (contact lens) · Lid hygiene · Antihistamine switch · Paradoxical epiphora explained · Sjögren’s screen · AACG safety-net
NICE CKS · Mrs. Chen: evaporative DED + screen + contact lenses + antihistamine · OSDI · 20-20-20 · Fluticasone switch
expand
💬 Opening & ICE
Opener: “Dry and streaming eyes all day at a screen as an accountant must be exhausting — and your lenses on top of that. Tell me more about when it started and what makes it worse.”
ICE — Ideas: Screen use + contact lenses — both correct; validate. Add: antihistamine (new); post-menopausal oestrogen deficiency; air conditioning.
ICE — Concerns: Vision damage. Reassure: “DED is uncomfortable but very rarely threatens vision when managed properly.”
ICE — Expectations: Drops that actually work. “The drops you have been using are preserved — the preservative is absorbed by your lenses and makes the dryness worse. I am prescribing PF drops — safe in lenses; and adding a lid routine that targets the cause.”
Paradoxical epiphora: “The dryness irritates the cornea → reflex tears flood the eye → these lack the oily layer → wash away immediately → surface dry again. The streaming IS the dry eye.”
Antihistamine challenge: “Your hay fever tablet has a mild drying effect on the eye surface — I want to switch you to a nasal spray instead — same hay fever control; no ocular drying effect. What do you think?”
✅ Key SCA Tasks (15pt)
Evaporative DED + lid hygiene (2pt): MGD confirmed (lid margin examination). Warm compress 5–10 min BD + lid massage + Blephasol BD — targets root cause. Drops alone do not address MGD.
PF drops correct (2pt): Contact lens wearer + >4×/day = PF mandatory. Hylo-Forte 0.2% ×4/day; safe in lenses. NOT preserved drops (BAK absorbed by lenses). Most common DED prescribing error.
Antihistamine switch (2pt): Cetirizine → fluticasone nasal spray (Flixonase). Anticholinergic → reduces lacrimal secretion. Fluticasone: no anticholinergic ocular effect; equivalent hay fever control.
Contact lens advice (2pt): PF drops: safe in lenses. Preserved drops: 15–30 min gap. Emergency: red/painful eye with lenses — remove lenses; same-day eye clinic/A&E. Never in red or sore eye.
Sjögren’s screen (2pt): Dry mouth asked; systemic features asked; result documented (negative today). “Sjögren’s screen: no dry mouth; no systemic features — not suspected at this consultation.”
20-20-20 + humidifier (1pt): Every 20 min; 20 feet; 20 seconds. Screen below eye level. Desk humidifier. Specific and practical advice.
OSDI baseline (1pt): Score documented; tells us severity; allows meaningful 6–8 week review. Target: ≥7-point reduction.
Omega-3 (1pt): Fish oil 1–2g/day OTC; adjunctive; modest anti-inflammatory benefit for MGD.
Ophthalmology referral criteria (1pt): If OSDI not improving at 6–8 weeks → ophthalmology; Ikervis if keratitis on slit lamp.
6–8 week review booked (1pt): OSDI re-score; drops frequency; lid hygiene compliance; antihistamine switch efficacy.
🔴 Preserved drops for contact lens wearer = automatic Tasks fail
🔴 Sjögren’s not screened = clinical deficiency
👥 Relating to Others (11pt)
Occupational + contact lens frustration (1pt): Named specifically; not generic
ICE: Ideas — validated + antihistamine added (1pt): Screen + lenses correct; antihistamine new information
ICE: Concerns — vision reassurance specific (1pt): “Not threatening your vision when treated”
ICE: Expectations — why OTC drops failed explained (1pt): Preserved; absorbed by lenses; worsened DED
Paradoxical epiphora (1pt): Clearly; compassionately; “streaming IS the dry eye”
Antihistamine switch collaboratively (1pt): “What do you think?” Shared decision
Contact lens reassurance (1pt): Goal = restore comfort; not ban lenses
Sjögren’s screen sensitively (1pt): “Not to alarm you — routine check”
Menopausal context (1pt): Raised sensitively; HRT opportunity
Realistic prognosis (1pt): Management not cure; 4–8 weeks for improvement
Closing question + pause (1pt): Mrs. Chen leaves: “I understand now why it has been happening. The plan makes sense.”
💊 Treatment Quick-Pick
Reviewed: July 2026 · citations verified against current NICE / UK guidance